lansoprazole and clarithromycin

lansoprazole has been researched along with clarithromycin in 439 studies

Research

Studies (439)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	88 (20.05)	18.2507
2000's	239 (54.44)	29.6817
2010's	103 (23.46)	24.3611
2020's	9 (2.05)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Dalvie, D; Loi, CM; Smith, DA	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Ido, K; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Takimoto, T; Taniguchi, Y; Yoshida, Y	2
Aisawa, T; Akagi, T; Fukuda, S; Fukushi, M; Mizuki, I; Munakata, A; Ohkawa, K; Sakata, Y; Shimoyama, T; Yoshida, Y	1
Fukuda, Y; Okui, M; Shimoyama, T; Tonokatsu, Y; Yamamoto, I	1
Ashworth, HM; Baron, JH; Gummett, PA; Harris, AW; Logan, RP; Misiewicz, JJ	1
Beattie, S; Cahill, RJ; Hamilton, H; Kilgallen, C; O'Morain, C; Xia, H	1
Johnson, CD; Ozmen, MM	1
Hentschel, E; Schütze, K	1
Fukuda, S; Fukuda, Y; Munakata, A; Shimoyama, T; Yoshida, Y	2
Cammarota, G; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Tursi, A	1
Baniukiewicz, A; Bielański, W; Gabryelewicz, A; Hahn, EG; Jedynak, M; Konturek, PC; Konturek, SJ; Kwiecień, N; Sito, E	1
Jaup, BH; Norrby, A	1
Herman, R; Konturek, JW; Konturek, SJ; Lorens, K; Tabor, S; Thor, P	1
Maeda, K; Nagashima, R; Ohno, S; Takahashi, T; Takeda, H	1
Fukuda, Y; Shimoyama, T; Tamura, K; Tonokatsu, Y; Tsujiai, T	1
Fujioka, T; Kodama, R; Kubota, T; Murakami, K; Nagai, J; Nasu, M; Nishizono, A; Tokieda, M	1
Cammarota, G; Cuoco, L; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Tursi, A; Veneto, G	1
Baron, JH; Gabe, SM; Harris, AW; Karim, QN; Langworthy, H; Misiewicz, JJ; Pryce, DI; Walker, MM	1
Bock, H; Mares, A	1
Kajiwara, M; Kawada, H; Kidaira, K; Kimura, K; Nishifuku, K; Sato, K; Sohara, H; Taniguchi, Y; Wang, XM	1
Akahane, T; Akamatsu, T; Gotoh, A; Katsuyama, T; Kawakami, Y; Kiyosawa, K; Shimizu, T	1
Bargiggia, S; Bianchi Porro, G; Lazzaroni, M	1
Ikemura, N; Imoto, I; Misaki, M; Nakao, K; Shibata, T; Taguchi, Y; Takaji, S; Yamauchi, K; Yamazaki, N	1
Chambers, S; Gould, SR; Lim, AG; Walker, C	1
Hoffman, JS	1
Hirakawa, T	1
Matsukura, N	1
Barnett, JL; Chey, WD; DelValle, J; Elta, GH; Fisher, L; Hasler, WL; Nostrant, T; Scheiman, JM	1
Harris, A	1
Lal, S; Sheikh, RM; Zuberi, BF	1
Haber, M; Kidd, S; Riff, DS; Rose, P; Siepman, N; Weissfeld, A	1
Arora, A; Graham, D; Haber, M; Harford, W; Lanza, F; Rose, P; Siepman, N; Weissfeld, A	1
Haber, M; Kidd, S; Krause, R; Rose, P; Sahba, B; Schwartz, H; Siepman, N; Weissfeld, A	1
Jaup, BK	1
Axon, AT; Chalmers, DM; Dixon, MF; Langworthy, H; Moayyedi, P; Shanahan, K; Tompkins, DS	1
Malfertheiner, P; Mégraud, F	1
Caputi, AP; Greco, S; Mazzaglia, G; Pagliaro, L	1
Dixon, JS; Pipkin, GA; Williamson, R; Wood, JR	1
Isomoto, H; Kohno, S; Matsunaga, K; Mizuta, Y; Oofukuji, M; Osabe, M; Syukuwa, S; Takeno, Y	1
Ido, K; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Seki, M; Takimoto, T; Taniguchi, Y; Yoshida, Y	1
Akamatsu, T; Gotoh, A; Katsuyama, T; Kawakami, Y	1
Fennerty, MB	1
Bardhan, KD; Cooper, BT; Dixon, MF; Harris, AW; Kerr, GD; Langworthy, H; Levi, S; Misiewicz, JJ; O'Morain, C; Piper, D	2
Abbasciano, V; Caselli, M; Ruina, M; Sartori, S; Trevisani, L; Verdianelli, G	1
El-Zimaity, HM; Graham, DY; Kim, JG; Osato, MS; Perng, CL	1
Johnsen, R; Lindsetmo, RO; Revhaug, A	1
Cunnane, K; Kelly, S; Laundon, J; McLoughlin, R; O'Connor, HJ	1
Scott, BB	1
Freston, J; Haber, M; Krause, R; Rose, P; Sahba, B; Schwartz, H; Siepman, N; Weissfeld, A	1
Liu, W; Lü, B; Xiao, S	1
Honda, T; Matsumoto, T; Mori, K; Nagatomi, Y; Takaba, M; Tsuneoka, H	1
Bierti, L; Bortoli, A; Colombo, E; Fertitta, AM; Lanzi, GL; Minoli, G; Spinzi, GC; Venturelli, R	1
Ahuja, V; Bal, C; Dhar, A; Sharma, MP	1
Hashimoto, Y	1
Higashi, Y; Kashima, K; Kodama, T; Sasaki, Y; Sawai, N; Tanahashi, T; Tatsumi, Y; Yamaoka, Y	1
Bazzoli, F; Berretti, D; De Luca, L; Fossi, S; Nicolini, G; Pozzato, P; Ricciardiello, L; Zagari, M	1
Cayla, R; de Mascarel, A; Forestier, S; Joubert-Collin, M; Lamouliatte, H; Mégraud, F; Zerbib, F	1
Kotze, D; Louw, JA; Marks, IN; Moola, S; Van Rensburg, CJ	1
De Fanis, C; Di Virgilio, M; Pantaleone, U; Pizzicanella, G; Russo, L; Sciampa, G; Silla, M; Spadaccini, A	1
Howden, CW; Hunt, RH	1
Ariake, K; Fujiki, K; Horiuchi, T; Ishii, K; Kumagai, J; Ohkusa, T; Sakurazawa, T; Shimoi, K; Suzuki, S; Takashimizu, I; Tanizawa, T	1
Asaka, M; Iinuma, K; Kato, S; Ohnuma, K; Ritsuno, H; Sugiyama, T	1
Fukuda, S; Haga, Y; Mikami, T; Munakata, A; Murata, Y; Shimoyama, T; Tanaka, M; Yamagata, R; Yoshimura, T	1
Fujita, T; Kobayasi, I; Mine, T; Suzuki, J	1
Boixeda, D; Gisbert, JP; Martín de Argila, C	1
Blandino, G; Carbone, M; Ciliberti, FA; Cusumano, V; De Sarro, A; De Sarro, GB; Fera, MT; Riggio, G	1
Iwasaki, A	1
Harasawa, S; Kouda, K; Kurumada, T; Miwa, T; Shirai, T; Tada, U; Takagi, A; Wada, T; Watanabe, S	1
Kawamura, N; Nakagawa, M; Nakagawa, S; Ooishi, M; Ooizumi, H; Saitou, M; Yoda, Y	1
Kihira, K; Kimura, K; Kumakura, Y; Sato, K; Sugano, K; Yoshida, Y	1
Liu, WZ; Shi, Y; Tytgat, GN; Wu, SM; Xiao, SD; Xu, WW; Zhang, DZ	1
Miwa, H; Murai, T; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Shimizu, H; Watanabe, S	1
Hassan, M; Ikezawa, K; Kashimura, H; Mutoh, H; Nakahara, A; Sawahata, T; Suzuki, K; Tanaka, N; Watanabe, T	1
Axon, AT; Everett, S; Langworthy, H; Mapstone, NP; Moayyedi, P; Neville, PM; Tompkins, D	1
Gisbert, JP	1
Bozzola, L; Di Mario, F; Fortunato, A; Franceschi, M; Leandro, G; Meli, S; Pilotto, A; Rassu, M; Scagnelli, M; Soffiati, G; Valerio, G	1
Arimori, K; Fujii, J; Masa, K; Miyamoto, S; Nakano, M; Nakayama, T	1
Hirai, S; Miwa, H; Murai, T; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Watanabe, S	1
Ducóns, JA; Ferrero, M; Gomollón, F; Guirao, R; Montoro, M; Santolaria, S	1
Fuchs, W; Hörner, M; Schlauch, D; Sellinger, M; Sieg, A	1
Cross, R; Grimley, CE; Illing, RC; Lismore, JR; Loft, DE; Nwokolo, CU; O'sullivan, M; Penny, A; Shebani, M	1
Bravo, LE; Correa, P; DeLany, JP; Mera, R; Realpe, JL	1
Ducóns, JA; Ferrero, M; García Cabezudo, J; Gomollón, F; Guirao, R; Montoro, M; Simón, MA	1
Cryer, B; Feldman, M; Lee, E; Sammer, D; Spechler, SJ	1
Fujishiro, M; Gotoda, T; Kondo, H; Oda, I; Ono, H; Saito, D; Yamaguchi, H	1
Hoshiya, S; Ishida, H; Itoh, T; Ninomiya, H; Saito, S; Shingaki, M; Takahashi, S; Tanaka, A; Tokunaga, K; Watanabe, K	1
Carpio, RE; Fock, KM; Ho, J; Hu, FL; Hu, PJ; Huang, NX; Kachintorn, U; Kullavanijaya, P; Lam, SK; Lesmana, L; Li, YY; Manan, C; Perez, JY; Phornphutkul, K; Qian, SC; Wong, BC; Xiao, SD	1
Akamatsu, T; Furihata, K; Miyabayashi, H; Shimizu, T; Ueno, I	1
Miwa, H; Murai, T; Nagahara, A; Ogihara, T; Ohkura, R; Ohta, K; Sato, K; Sato, N; Takei, Y; Yamada, T	1
Bueno, ML; Castro, LP; Coelho, LG; Gomes, BS; Lopes, LG; Martins, GM; Passos, MC	1
Brousal, A; Kearney, DJ	1
Ducóns, JA; Gomollón, F; Guirao, R; Montoro, M; Santolaria, S; Vera, J	1
Beglinger, C; Drewe, J; Lehmann, FS; Terracciano, L	1
Lin, CH; Peters, J; Rabah, R; Shashidhar, H; Thomas, R; Tolia, V	1
Azuma, T; Ito, S; Ito, Y; Kato, T; Kuriyama, M; Miyaji, H; Suto, H; Yamazaki, Y	1
Kaushik, SP; Vu, C	1
Ammon, S; Kees, F; Klotz, U; Treiber, G	1
Bhasin, DK; Pathak, CM; Ray, P; Sharma, BC; Singh, K	1
Joubert-Collin, M; Lamouliatte, H; Perie, F	1
Imai, T; Konno, M; Muraoka, S; Takahashi, M	1
Kurosawa, A; Minowa, T; Miwi, H; Murai, T; Nagahara, A; Ohkura, R; Ohtaka, K; Sato, K; Sato, N; Yamada, T	1
Bart, A; Beumer, HJ; Cattoli, G; Klaver, PS; Kuipers, EJ; Kusters, JG; Pot, RG; Robijn, RJ; van der Gaag, I; van Vugt, R; Vandenbroucke-Grauls, CM	1
Buzás György, M; Illyés, G; Székely, E; Széles, I	1
Howden, CW	1
Huang, AH; Huang, CC; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB	1
Botta, F; Chiarbonello, B; Fasoli, A; Giannini, E; Lantieri, PB; Malfatti, F; Risso, D; Romagnoli, P; Savarino, V; Testa, R	1
Akura, Y; Fujiwara, T; Hamazaki, K; Ikeda, Y; Matsumoto, T; Murashima, N; Nishisita, C; Umekawa, Y	1
Fanti, L; Guslandi, M; Ieri, R; Mezzi, G; Passaretti, S; Testoni, PA	1
Aegerter, PH; de Mascarel, A; Lavergne, A; Megraud, F; Molina, T; Palazzo, L; Rambaud, JL; Ruskoné-Fourmestraux, A	1
Asaka, M; Kashiwagi, S; Miyake, K; Nomura, H; Sugiyama, T	1
Asaka, M; Hokari, K; Kagaya, H; Kato, M; Sugiyama, T; Takeda, H	1
Kohgo, Y; Satoh, T; Shibata, N; Tanabe, H; Watari, J; Yokota, K	1
Ohkusa, T; Watanabe, M	1
Harada, H; Kobayashi, S; Miki, H; Ohmori, M; Sotozono, M; Uraoka, T; Yamanoi, Y	1
Arakawa, Y; Ishii, Y; Kato, K; Kawamura, F; Kawamura, Y; Komuro, S; Nagata, T; Nemoto, N; Nishinarita, S; Sugitani, M; Takahashi, Y; Yanai, M	1
Bianchi Porro, G; Imbesi, V; Maconi, G; Parente, F; Russo, A; Vago, L	1
Furuta, T; Hanai, H; Ishizaki, T; Kaneko, E; Ohashi, K; Shirai, N; Sugimura, H; Takashima, M; Xiao, F	1
Endo, H; Higuchi, S; Ohmi, N; Yoshida, H	2
Avidan, B; Bar-Meir, S; Keller, N; Melzer, E	1
Boknik, P; Domschke, W; Fischer, H; Huber, V; Konturek, JW; Luess, H; Neumann, J; Schmitz, W	1
Chan, CK; Chu, KM; Fung, FM; Hu, FL; Hu, WH; Hui, WM; Kung, NN; Lai, KC; Lam, SK; Lau, GK; Liu, XG; Wang, WH; Wong, BC; Wong, WM; Yuen, MF	1
Belmonte, A; Cavaliere, C; Ciliberto, E; Fiocca, R; Frandina, C; Giglio, A; Luzza, F; Pallone, F; Saccà, N; Trimboli, V	1
Cathomas, G; Dent, J; Fried, M; Guldenschuh, I; Menne, D; Schwizer, W; Thumshirn, M	1
Hojo, M; Miwa, H; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Yamada, T	1
Bateson, MC	1
Kawabe, T; Maeda, S; Ogura, K; Okamoto, M; Omata, M; Shiratori, Y; Yamaji, Y; Yoshida, H	1
Kawamura, K; Kimura, M; Mukai, K; Nakamura, S; Nakamura, T; Sawa, H; Shiku, H; Suzuki, H; Toyoda, H; Yamaguchi, M	1
Adachi, K; Fujishiro, H; Hashimoto, T; Hattori, S; Hirakawa, K; Ishihara, S; Ishimura, N; Kaji, T; Kawamura, A; Kinoshita, Y; Niigaki, M; Sato, H; Watanabe, M	1
Fung, TT; Hui, PK; Lam, KM; Lau, CF; Loo, CK; Tung, SY; Wong, AM	1
Beglinger, C; Burnand, B; Froehlich, F; Gonvers, JJ; Hildebrand, P; Saraga, E; Schneider, C; Vader, JP; Wietlisbach, V	1
Bianchi Porro, G; Cucino, C; Imbesi, V; Maconi, G; Russo, A	1
Burm, M; Faigel, D; Fennerty, MB; Kelly, C; Magaret, N; Peterson, W	1
Aragona, F; Di Vita, G; Leo, P; Montalto, G; Patti, R	1
Hsu, CT; Kuo, CF; Wang, CS; Wang, TH; Yang, JC; Yang, KC	1
Chey, WD; Fendrick, AM	1
Ho, B; Ling, KL; Luman, W; Ng, HS	1
Asaka, M; Hamashima, C; Ikeda, S; Tamamuro, T	1
Asaka, M; Fujioka, T; Fukuda, Y; Kato, M; Kimura, K; Kobayashi, S; Kuwayama, H; Satoh, K; Shimizu, K; Shimoyama, T; Sugiyama, T; Takemoto, T	2
Endo, H; Higuchi, S; Ohmi, N; Ohta, K; Yoshida, H	1
Mai, AL; Mai, KT	1
Ammon, S; Klotz, U; Treiber, G; van Doorn, LJ; Walker, S; Wittig, J	1
Aoyama, N; Okumura, K; Shirasaka, D	1
Bavbek, N; Koçkar, C; Oztürk, M	1
Fujioka, T; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R	1
Goto, H; Hino, R; Kikuta, T; Ota, A; Tsuji, H	1
Furukawa, F; Sakurane, M; Shiotani, A	1
Alampi, G; Bazzoli, F; Berretti, D; De Luca, L; Di Pietro, C; Fossi, S; Morelli, P; Nicolini, G; Pozzato, P; Ricciardiello, L; Roda, E; Zagari, RM	1
Chang, CS; Chen, GH; Lai, CH; Poon, SK; Su, J; Wang, WC; Yang, CC	1
Bartolozzi, F; Cammarota, G; Candelli, M; Cremonini, F; Di Caro, S; Gasbarrini, A; Lupascu, A; Nista, EC; Ojetti, V; Zocco, MA	1
Barbier, C; Benhamou, PH; Bergeret, M; Dupont, C; Gottrand, F; Husson, MO; Kalach, N; Raymond, J	1
Koyama, H; Nomura, F; Odaka, T; Saisho, H; Yamaguchi, T	1
Nakamura, T	1
Asaka, M; Kato, M; Komatsu, Y; Shimizu, Y; Sugiyama, T; Takeda, H	1
Satoh, K	2
Ohkusa, T; Sato, N	1
Miwa, H; Miyazaki, A; Nagahara, A; Sato, N	1
Furuta, T; Shirai, N	1
Mitsuno, Y; Yoshida, H	1
Asaka, M; Kagaya, H; Kato, M	1
Inoue, K; Sugano, K	1
Kurosawa, A; Miwa, H; Sato, N	1
Haruma, K; Kamada, T; Kusunoki, H	1
Sawada, A	1
Chiba, T; Watanabe, T	1
Kawata, H; Satoh, K	1
Azuma, T; Ito, S; Yamazaki, Y	1
Kiriyama, Y; Koizumi, K; Kuwayama, H; Ohara, T; Suga, M; Suzuki, K; Takahashi, M; Takata, H	1
Isomoto, H; Kohno, S	1
Baumann, R; Buri, P; Cunningham, M; Dederding, JP; Gallaz, L; Girard, L; Godin, N; Merki, H; Metry, JM; Sitavanc, R; Wermeille, J; Zelger, G	1
Sugano, K	1
Dhir, V; Laine, L	1
Calvet, X; Gisbert, JP; Vallve, M; Vergara, M	1
Inaba, T; Kawai, K; Miyoshi, M; Mizuno, M; Oguma, K; Okada, H; Take, S; Tsuji, T; Yokota, K	1
Adamek, HE; Riemann, JF; Schilling, D	1
Asaka, M; Shimodan, M; Sugiyama, T; Tsuchida, M; Yokota, K	1
Hirayama, Y; Kanisawa, Y; Kogawa, K; Kohda, K; Koike, K; Kuga, T; Kuroiwa, G; Niitsu, Y; Sato, Y	1
Echizen, H; Nachi, S; Ohnishi, A; Ushiama, H	1
Endo, H; Higuchi, S; Ohmi, N; Ohta, K; Suga, T; Yoshida, H	1
Fujimoto, K; Fujise, T; Ishibashi, S; Iwakiri, R; Kawasaki, S; Kikkawa, A; Oda, K; Ootani, A; Ootani, H; Sakata, H; Shimoda, R; Tadano, J; Tsunada, S; Yoshida, T	1
Boon, YH; Cheng, CS; Chian, LC; Chiu, TC; Kaushik, S; Vu, C	1
Nakamura, T; Terano, A	1
Chen, JH; Lin, MD; Lin, YS; Lo, CY; Sheu, BS; Wu, HW; Wu, JJ	1
Endo, H; Kohno, Y; Suga, T; Yoshida, H	1
Furukawa, K; Hisabe, T; Imamura, K; Kanda, M; Kikuchi, M; Matsui, T; Ohshima, K; Tsuda, S; Yao, T	1
Coyle, W; Dunteman, T; Nemec, R; Sullivan, B	1
Abe, H; Arita, T; Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Sato, S	1
Borner, K; Koeppe, P; Kotwas, J; Lode, H; Mainz, D	1
Chung, IS; Chung, KW; Kim, JI; Kim, JK; Park, SH; Sun, HS	1
Rai, R; Rai, S	1
Bueno, ML; Castro, LP; Coelho, LG; Lopes, LG; Martins, GM; Miranda, CH; Passos, MC; Sanches, BS	1
Habu, Y; Hayakumo, T; Inokuchi, H; Kawabata, H; Kawai, K; Kimoto, K; Kiyota, K; Kobayashi, M; Kutsumi, H; Mizuno, S; Nakajima, M; Oyasu, K; Tomioka, H	1
Aoyama, N; Kasuga, M; Kita, T; Kuroda, K; Maekawa, S; Miki, I; Okumura, K; Sakaeda, T; Sakai, T; Shirasaka, D; Tamura, T; Wambura, CM	1
Arima, N; Tsudo, M	1
Furusu, H; Inoue, K; Isomoto, H; Kohno, S; Mizuta, Y; Murase, K; Murata, I; Nishiyama, H; Omagari, K; Shikuwa, S	1
Asaka, M	2
Hamajima, N; Ikehara, Y; Matsuo, K; Matsuura, A; Nakamura, T; Suzuki, T; Tajima, K; Tominaga, S	1
Chayama, K; Haruma, K; Ito, M; Kamada, T; Masuda, H; Miyamoto, M; Nishisaka, T; Sumioka, M; Tanaka, S; Yoshihara, M	1
Huang, AH; Huang, JJ; Sheu, BS; Wu, JJ; Yang, HB	1
Ford, A; Moayyedi, P	1
Björkman, A; Granström, M; Hoang, TT; Phung, DC; Sörberg, M; Wheeldon, TU	1
Chen, TK; Huang, SH; Lai, YC; Lee, CL; Wang, TH; Wu, CH; Yang, SS	1
Uthaisaengsook, W	1
Demleitner, K; Fischbach, W; Fuchs, W; Layer, P; Leodolter, A; Malfertheiner, P; MOssner, J; Stolte, M	1
Cohen, L; Fedorak, RN; Lambert, J; Vanjaka, A; Veldhuyzen van Zanten, S	1
Hoshino, Y; Ishii, H; Kurabayashi, K; Masaoka, T; Minegishi, Y; Nomura, S; Suzuki, H; Suzuki, M	1
Chan, CK; Chan, OO; Chu, KM; Hu, HC; Hui, WM; Kwok, KF; Lai, KC; Lam, SK; Wong, BC; Wong, WM	1
Aoyama, N; Fukuda, M; Kachi, M; Kasuga, M; Kuroda, K; Maekawa, S; Miki, I; Shirasaka, D; Tamura, T; Wambura, C; Watanabe, Y	1
Inaba, T; Ishiki, K; Mizuno, M; Nagahara, Y; Oguma, K; Okada, H; Shiratori, Y; Take, S; Yamamoto, K; Yokota, K; Yoshida, T	1
Aiba, M; Hamaguchi, K; Katsube, T; Konno, S; Ogawa, K	1
El-Omar, EM; Furuta, T; Ishizaki, T; Ohashi, K; Rabkin, CS; Shirai, N; Sugimura, H; Xiao, F	1
Asaka, M; Sugiyama, T	1
Amarapurkar, A; Amarapurkar, D; Das, HS; Makesar, M	1
Ahuja, V; Bal, C; Bhatia, V; Das, B; Sharma, MP	1
Altintas, E; Aydin, O; Camdeviren, H; Sezgin, O; Ulu, O	1
Granström, M; Hoang, TT; Nilsson, LE; Phuncarg, DC; Sörberg, M; Wheeldon, TU	1
Fujiyama, Y; Inoue, T; Kakinoki, R; Sakabe, H; Yagi, Y; Yoshikawa, K	1
Asaumi, N; Niiya, K; Niiya, M; Shibakura, M; Tanimoto, M; Yoshida, C	1
Karaoglu, AO; Yasa, MH; Yukselen, V	1
Ishii, H; Kamiya, AG; Masaoka, T; SuzukiKurabayashi, HK	1
Itoh, K; Itoh, M; Joh, T; Kataoka, H; Kondo, Y; Nomura, T; Ohara, H; Oshima, T; Sasaki, M; Tanida, S	1
Güliter, S; Kandilci, U	1
Bago, J; Bago, P; Belosić Halle, Z; Bevanda, M; Bilić, A; Galović, A	1
Fujioka, T; Kodama, M; Miyajima, H; Murakami, K; Nasu, M; Ogata, M; Ohtsuka, E; Okimoto, T; Saburi, Y; Sato, R; Watanabe, K	1
Cao, X; Kaminishi, M; Kumagai, T; Mizoshita, T; Nozaki, K; Shimizu, N; Tatematsu, M; Tsukamoto, T	1
Fukuda, S; Fukushi, M; Mikami, T; Munakata, A; Shimoyama, T	1
Fujioka, T; Kashimura, K; Kodama, M; Miura, M; Miyajima, H; Murakami, K; Nasu, M; Okimoto, T; Ootsu, S; Sato, R; Watanabe, K	1
Iinuma, K; Kato, S; Konno, M; Maisawa, S; Nakayama, Y; Shimizu, T; Tajiri, H; Toyoda, S; Yoshimura, N	1
Hirashima, N; Ito, K; Kato, A; Kato, H; Kondo, H; Matsunaga, S; Nukaya, H; Sakakibara, K; Sakamoto, T; Tanaka, Y	1
Bellotti, M; Botta, F; Chiarbonello, B; Cotelessa, T; Emanuela, T; Fumagalli, A; Giannini, E; Malfatti, F; Milazzo, S; Podestà, E; Polegato, S; Testa, R	1
Imase, K; Ishida, H; Itoh, T; Kai, A; Sugano, H; Takahashi, S; Tanaka, A; Tokunaga, K; Watanabe, K	1
Iinuma, K; Kato, S; Minoura, T; Ohyauchi, M; Ozawa, K; Sekine, H; Shimosegawa, T	1
Fukuda, Y; Hori, K; Matsumoto, T; Miwa, H; Ohkusa, T; Shintani, S; Tanaka, J; Tomita, T	1
de Mascarel, A; Dubus, P; Lavergne-Slove, A; Megraud, F; Merlio, JP; Ruskone-Fourmestraux, A	1
Chang, CC; Chen, SH; Fang, CL; Hsieh, CR; Lee, YJ; Lien, GS; Lou, HY; Pan, S	1
Feng, LY; Jiang, SL; Yao, XX	1
Munakata, A; Saito, M; Sugawara, K; Takahata, T; Tateishi, T; Uno, T; Yasui-Furukori, N	1
Färkkilä, MA; Heikkinen, MT; Koivisto, TT; Koskenpato, JP; Rautelin, HI; Voutilainen, ME	1
Miura, M; Sugawara, K; Suzuki, T; Tada, H; Tateishi, T; Uno, T; Yasui-Furukori, N	1
Caner, B; Gedik, GK; Karaduman, A; Sivri, B	1
Cartell, A; Edelweiss, MI; Francesconi, CF; Mazzoleni, LE; Ott, EA; Prolla, JC; Rivero, LF; Sander, GB; Somm, G; Theil, AL; Uchôa, DM; Wortmann, AC	1
Niv, Y	2
Cao, Q; Si, JM; Wu, JG	1
Egashira, T; Furuta, T; Hishida, A; Ishizaki, T; Kenmotsu, K; Kodaira, M; Nagano, M; Nakamura, A; Ohashi, K; Sagehashi, Y; Shirai, N; Sugimoto, M; Ueda, K; Yoneyama, M	1
Akamatsu, T; Hidaka, E; Matsuzawa, K; Okiyama, Y; Ota, H; Sano, K	1
Furuta, T; Hishida, A; Ishizaki, T; Nakamura, A; Shirai, N; Sugimoto, M	1
Asaka, M; Ehira, N; Imamura, M; Kanamori, H; Kawamura, T; Masauzi, N; Mori, A; Obara, S; Ogura, N; Tanaka, J; Tsutsumi, Y; Umehara, S; Yamato, H	1
Klotz, U; Schwab, M; Treiber, G	1
Cho, YS; Kim, SS; Konkin, TA; Meitner, P; Moss, SF; Resnick, MB	1
Carvalhaes, A; Magalhães, AF; Natan-Eisig, J; Paraíso-Ferraz, JG; Trevisan, M; Zaterkaad, S	1
Arai, D; Chen, G; Fukuchi, K; Gomi, K; Kikuchi, R; Takeuchi, Y	1
Baggett, HC; Bruce, MG; Dunaway, E; Gessner, BD; Gold, BD; Muth, PT; Parkinson, AJ	1
Hibi, T; Ishii, H; Masaoka, T; Sakai, G; Suzuki, H	1
Ateş, Y; Bağci, S; Ciğerim, M; Dağalp, K; Kadayifçi, A; Karslioğlu, Y; Savaş, MC; Uygun, A; Yeşilova, Z	1
Cengiz, DU; Güliter, S; Keleş, H; Kolukisa, E; Ozkurt, ZN	1
Krishna, M; Lalmuanpuii, J	1
Demirturk, L; Gurbuz, AK; Ozel, AM; Ozturk, R; Yazgan, Y; Yildirim, S	1
Aoyagi, K; Maeda, K; Nishiyama, M; Sakisaka, S	1
Kawai, T; Kawakami, K; Moriyasu, F; Takagi, Y	1
Furuta, T; Miura, S; Okudaira, K; Shirai, N; Sugimoto, M	1
Takeda, H	1
Yanaka, A; Zhang, S	1
Nagahara, A; Sato, N	1
Furuta, T; Nakamura, A; Shirai, N; Sugimoto, M	1
Fujishiro, M; Kobayashi, K; Oka, M; Omata, M	1
Fujishiro, M; Ichinose, M; Oka, M; Omata, M	1
Asaka, M; Kato, M; Nakagawa, M; Nakagawa, S; Shimizu, Y	1
Konno, M	1
Katoh, H; Kuwano, H; Miyazaki, T; Tsukada, K	1
Bertin, P; Broutet, N; Combe, B; Joubert-Collin, M; Lamouliatte, H; Mégraud, F; Perié, F; Schaeverbeke, T; Zerbib, F	1
Barros, SG; Cartell, A; Edelweiss, MI; Francesconi, CF; Fritscher, LG; Mazzoleni, LE; Ott, EA; Polanczyk, CA; Prolla, JC; Rivero, LF; Sander, GB; Theil, AL; Uchôa, DM; Wortmann, AC	1
Ariyama, I; Furusyo, N; Hayashi, J; Kochi, S; Kubo, N; Murata, M	1
Chen, JY; Ji, F; Li, YM; Ning, JW; Wang, QY; Wang, ZW	1
Asaka, M; Kato, M; Katsuyama, T; Kikuchi, S; Tominaga, S	1
Arakawa, T; Asaka, M; Fujioka, T; Haruma, K; Ishii, H; Kinoshita, Y; Kobayashi, K; Sakaki, N; Sakamoto, C; Shimosegawa, T; Sugiyama, T; Takahashi, S; Terano, A; Yoshikawa, T	1
Hamajima, N; Hirose, K; Ito, H; Matsuo, K; Nakamura, T; Saito, T; Sawaki, A; Suzuki, T; Tajima, K; Wakai, K; Yamao, K	1
Kaneko, S; Niioka, T; Sugawara, K; Tateishi, T; Uno, T; Yasui-Furukori, N	1
Classen, M; Li, J; Lin, SR; Liu, WD; Ma, JL; Pan, KF; Shen, L; Xiao, SD; You, WC; Zhang, L	1
Hayashi, K; Hisanaga, Y; Ichikawa, H; Kawachi, T; Kawase, N; Kiriyama, S; Kumada, T; Kuzuya, T; Nonogaki, K; Shimizu, J; Sone, Y; Tanikawa, M; Toyoda, H; Yamauchi, T	1
Akyol Erikci, A; Ozturk, A; Sayan, O	1
Ang, TL; Chan, YH; Chua, TS; Fock, KM; Ng, TM; Tan, JY; Teo, EK	1
Fujioka, T; Inoue, K; Kodama, M; Miyajima, H; Murakami, K; Okimoto, T; Ono, M; Otsu, S; Sato, R; Watanabe, K	1
Apikoglu-Rabus, S; Besisik, F; Dulger, G; Izzettin, FV; Sancar, M; Tozun, N	1
Kast, RE	1
Ahlroos, T; Korpela, R; Myllyluoma, E; Rautelin, H; Tynkkynen, S; Veijola, L	1
Furuta, T; Hishida, A; Ishizaki, T; Iwaizumi, M; Kodaira, M; Kuriyama, S; Nogaki, A; Ohashi, K; Shirai, N; Sugimoto, M; Terakawa, I; Yamade, M	1
Bertoli Neto, JL; Bertoli, CF; Bueno, AG; Lourenço, LG; Sabbi, AR; Ulbrich, FS	1
Bernasconi, G; Calafatti, SA; Deguer, M; Ecclissato, CC; Marchioretto, MA; Moraes, LA; Ortiz, RA; Pedrazzoli, J; Ribeiro, ML	1
Arakawa, Y; Hatta, Y; Hayashi, I; Iwamoto, M; Kato, K; Kurihara, R; Kurosaka, H; Matsukawa, Y; Mizuno, S; Sawada, S	1
Hayashida, Y; Itatsu, T; Kubota, M; Miwa, H; Miyazaki, A; Nagahara, A; Sato, N	1
Cindoruk, M; Deger, SM; Kan, E; Karakan, T; Unal, S; Yetkin, I	1
Ishiki, K; Ishioka, H; Mizuno, M; Nagahara, Y; Oguma, K; Okada, H; Take, S; Yokota, K; Yoshida, T	1
Aoki, T; Itoi, T; Kawai, T; Kawakami, K; Matsumoto, Y; Mikinori, K; Moriyasu, F; Noguchi, N; Rimbara, E; Sasatsu, M; Takagi, Y; Takei, K; Watanebe, K	1
Kamiya, S	1
Anbo, T; Asaka, M; Fujinaga, A; Hagiwara, T; Imamura, A; Kato, M; Nakagawa, M; Nakagawa, S; Shimizu, Y; Suga, T; Takeda, H; Uchida, T; Yamamoto, J	1
Cindoruk, M; Dursun, A; Erkan, G; Karakan, T; Unal, S	1
Furuta, T; Hishida, A; Ikuma, M; Ishizaki, T; Kodaira, C; Nishino, M; Shirai, N; Sugimoto, M	1
Chang, WL; Chen, WY; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB	1
Furuta, T; Hishida, A; Ikuma, M; Ishizaki, T; Kodaira, C; Kumagai, J; Matsushita, F; Nakajima, H; Nishino, M; Senoo, K; Shirai, N; Sugimoto, M; Umemura, K; Watanabe, H; Yamade, M	1
Arakawa, T; Haruma, K; Higuchi, K; Joh, T; Kobayashi, K; Murakami, K; Sugiyama, T; Suzuki, H; Terano, A; Yoshikawa, T	1
Richter, JA; Seabrook, ME; Shmunes, E	1
Bagci, S; Ilgan, S; Kadayifci, A; Safali, M; Uygun, A	1
Harris, EJ; Krishna, U; Peek, RM; Perez-Perez, GI; Romero-Gallo, J; Washington, MK	1
Hayakari, M; Miura, M; Niioka, T; Suzuki, T; Tateishi, T; Uno, T; Yasui-Furukori, N	1
Amenta, PS; Das, KK; Das, KM; Geng, X; Kohgo, Y; Lin, JJ; Tanabe, H; Tanaka, A; Watari, J	1
Cole, CR; Frem, JC; Gold, BD; Shehata, BM	1
Asaka, M; Itoh, T; Kato, M; Kubota, K; Nakagawa, M; Ono, S; Ono, Y; Shimizu, Y	1
Ching, SS; Jenkinson, LR; Sabanathan, S	1
Amagai, K; Asaka, M; Fukase, K; Hayashi, S; Inoue, K; Kato, M; Kikuchi, S; Okamoto, S; Terao, S; Uemura, N	1
Hungin, AP; Jackson, W; Mason, JM; Raghunath, AS	1
Isomoto, H; Ito, M; Kohno, S; Nishiyama, H; Okamoto, K; Shikuwa, S	1
Cho, YK; Choi, WH; Hong, CH; Hong, EJ; Jeon, WK; Kim, BI; Kim, HJ; Oh, SJ; Park, DI; Park, JH; Shon, CI; Song, MJ	1
Arakawa, T; Fujiwara, Y; Higuchi, K; Hino, M; Koh, K; Nakao, T; Okazaki, H; Oshitani, N; Tanigawa, T; Tominaga, K; Tsumoto, C; Watanabe, K; Watanabe, T; Yamagami, H; Yamane, T	1
Chae, HS; Chang, YW; Cho, CM; Chun, HJ; Chung, IS; Hong, SJ; Jeon, WJ; Jung, HC; Kim, HU; Kim, JG; Kim, JW; Kim, N; Kim, SW; Kim, TN; Lee, GH; Lee, KJ; Lee, OJ; Lee, SW; Park, CG; Park, CH; Park, JJ; Park, JY; Park, KS; Park, MI; Park, SH; Seo, GS; Seol, S; Shim, KN; Shin, JE; Shin, WC; Shin, YW; Song, GA; Won, SY; Yoon, BC	1
Bengtsson, C; Granström, M; Hoang, TT; Nguyen, GK; Nguyen, TV; Phung, DC; Sörberg, M	1
Cheon, JH; Kim, JH; Kim, TI; Kim, WH; Lee, SK; Lee, YC	1
Balkarli, A; Baştürk, A; Cerçi, S; Senol, A; Songür, Y	1
Fukase, K; Kawata, S; Mabe, K; Matsuda, T; Oizumi, H; Shibata, A; Takahashi, M; Takeda, H; Tsukuma, H	1
ASAKA, M; HASHINO, S; IMAMURA, M; KAHATA, K; KONDO, T; MORITA, R; OKADA, K; ONOZAWA, M; TAKAHATA, M	1
Mahachai, V; Sirimontaporn, N; Thong-Ngam, D; Tumwasorn, S	1
Angelini, R; Pontone, P; Pontone, S; Standoli, M	1
Hori, S; Inoue, M; Kawahara, Y; Kawano, S; Okada, H; Onishi, Y; Shiratori, Y; Takenaka, R; Toyokawa, T; Yamamoto, K	1
Dutta, U; Kochhar, R; Noor, MT; Sidhu, GS; Singh, K; Udawat, H; Vaiphei, K	1
Hirata, Y; Joh, T; Kamiya, T; Kasugai, K; Kataoka, H; Mizoshita, T; Ogasawara, N; Sasaki, M; Shimura, T; Tanida, S; Utsumi, K	1
Akgöllü, E; Akkiz, H; Bayram, S; Bekar, A; Ozdil, B; Sandikçi, M	1
Ashida, C; Higashida, A; Kawara, F; Mamori, S; Ohnishi, K; Senda, E; Takeda, A; Yamada, H	1
Abue, M; Kon, H; Noguchi, T; Nomura, E; Onodera, H; Ota, Y; Suzuki, M; Suzuki, S; Tateno, H; Uchimi, K	1
Gon, Y; Hemmi, A; Iwamoto, M; Kato, K; Matsukawa, Y; Mizuno, S; Sawada, S; Shirinskaya, N; Takeuchi, J	1
Arisawa, T; Hirata, I; Ishizuka, T; Maeda, Y; Nakamura, M; Okubo, M; Shibata, T; Tahara, T; Yonemura, J; Yoshioka, D	1
Hibi, T; Hosoe, N; Ikeda, Y; Imaeda, H; Iwao, Y; Kameyama, K; Kizaki, M; Ogata, H; Suzuki, H; Yaguchi, T	1
Bekar, O; Gulten, M; Yilmaz, Y	1
Aydemir, S; Cabuk, M; Demircan, N; Eren, H; Harmandar, FA; Tekin, IO	1
Kilic, ZM; Nadir, I; Ozin, Y; Sezgin, O; Yonem, O	1
Atwood, JL; Dalgarno, SJ; Tian, J	1
Mahachai, V; Sirimontaporn, N; Thong-Ngam, D; Tumwasorn, S; Vilaichone, RK	1
Asaka, M; Furukawa, K; Furuta, T; Inaba, T; Ishii, N; Kamoshida, T; Kato, M; Konda, Y; Nomura, H; Sasaki, M; Shirai, T; Sugimoto, M; Tomita, T	1
Niioka, T	1
Agrawal, A; Chandra, M; Gupta, A; Koowar, S	1
Ince, AT; Kesici, B; Polat, Z; Saglam, M; Toros, AB; Uygun, A	1
Fujioka, T; Kodama, M; Murakami, K; Okimoto, T; Sato, R; Watanabe, K	1
Goto, Y; Hamajima, N; Inoue, S; Kamiya, Y; Kawai, S; Kondo, T; Kurata, M; Tamura, T	1
Demir, M; Erbayrak, M; Gokturk, HS; Sakalli, M; Unler, GK; Yilmaz, U	1
Choi, JH; Chun, HJ; Jung, SW; Kim, JH; Kim, SY; Koo, JS; Lee, SW; Park, JJ; Yim, HJ	1
Bay, A; Coskun, E; Leblebisatan, G; Yalcin, AS	1
Çetinkaya, ZA; Coşgun, S; Güzelbulut, F; Kurdaş, OÖ; Sezikli, M; Yeşil, A	1
Anderson, GL; Baker, LH; Bravo, LE; Chey, WD; Correa, P; Crowley, JJ; Dominguez, RL; Ferreccio, C; Goodman, GE; Greenberg, ER; Herrero, R; Lazcano-Ponce, EC; Martínez, ME; Meza-Montenegro, MM; Morgan, DR; Peña, EM; Peña, R; Salazar-Martínez, E; Torres, J; Valdivieso, M	1
Francesconi, CF; Mazzoleni, LE; Sander, GB	1
Basu, PP; Flynn, M; Krishnaswamy, N; Pacana, T; Rayapudi, K; Shah, NJ	1
Annibale, B; Hassan, C; Sbrozzi-Vanni, A; Severi, C; Vannella, L; Zullo, A	1
Chang, LL; Chen, YH; Huang, YK; Kuo, CH; Kuo, FC; Lee, YC; Wang, SS; Wang, TH; Wang, WM; Wu, DC; Wu, MC	1
Erdur, B; Gurbuz, ED; Ozturk, Y; Yilmaz, O	1
Choi, JH; Chun, HJ; Hyun, JJ; Jung, SW; Kim, SY; Koo, JS; Lee, SW; Park, JJ; Yim, HJ	1
Bengtsson, C; Granström, M; Hoang, TT; Nguyen, GK; Nguyen, TV; Phung, DC; Sörberg, M; Yin, L	1
Chung, JW; Hahm, KB; Jeong, JY; Jung, YK; Kim, JH; Kim, YJ; Kwon, KA; Lee, JJ; Lee, SM; Yun, SC	1
Chang, CY; Chang, WH; Chen, CC; Chen, MJ; Fang, YJ; Hsu, SJ; Hsu, YC; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Tseng, CH; Tseng, PH; Wang, HP; Wu, MS; Yang, UC	1
Cho, WY; Choi, IJ; Jung, HC; Keum, B; Kim, JG; Kim, SG; Lee, JH; Lee, YC; Park, BJ; Park, SK; Song, HJ	1
Anderson, GL; Baker, LH; Bravo, LE; Chey, WD; Correa, P; Crowley, JJ; Dominguez, RL; Ferreccio, C; Goodman, GE; Greenberg, ER; Herrero, R; Lazcano-Ponce, EC; Martínez, ME; Meza-Montenegro, MM; Morgan, DR; Peña, EM; Peña, R; Salazar-Martínez, E; Sexton, R; Torres, J; Valdivieso, M	1
Malfertheiner, P	1
Imai, Y; Inokuma, T; Matsumoto, T	1
Botero, ML; Cárdenas, A; Forero, JD; Rey, M; Sierra, F	1
Dubois, A; Francis, J; Jia, Y; Liu, H; McAvoy, TJ; Merrell, DS; Nieroda, C; Sardi, A; Semino-Mora, C; Studeman, K; Testerman, TL; Whitmire, JM	1
Chen, A; Chen, JJ; Hsu, PI; Hsu, WH; Kuo, CH; Kuo, FC; Liu, CJ; Liu, MK; Lu, CY; Su, YC; Wu, DC; Wu, IC; Yu, FJ	1
Asaoka, D; Ito, M; Kawai, T; Kawakami, K; Kurihara, N; Matsuhisa, T; Mine, T; Mizuno, S; Nagahara, A; Nishizawa, T; Ohkusa, T; Omata, F; Sakaki, N; Sasaki, H; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K; Torii, A	1
Benzer, E; Bilir, G; Gokcan, H; Onal, IK; Oztas, E	1
Doğan, Z; Ergül, B; Filik, L; Sarikaya, M	2
Ateş, Y; Avşar, E; Aytuğ, N; Bektaş, A; Bölükbaş, C; Dinçer, D; Ellidokuz, E; Erzin, Y; Güliter, S; Kaymakoğlu, S; Kocakaya, O; Onuk, MD; Poturoğlu, S; Taşan, G; Tiftikçi, A; Türkay, C; Yıldırım, B; Yılmaz, U	1
Adachi, E; Fujii, T; Iwamoto, A; Kikuchi, T; Koga, M; Koibuchi, T; Ohno, N; Okame, M; Ota, Y; Oyaizu, N; Sato, H; Takaya, S	1
Barbaro, F; Cammarota, G; Campanale, M; Cesario, V; D'Angelo, G; De Pasquale, T; Di Rienzo, TA; Franceschi, F; Gasbarrini, A; Gigante, G; Nucera, E; Ojetti, V; Pecere, S; Rizzi, A; Schiavino, D	1
Abdalla, AF; Al-Hussaini, AS; El-Baz, R; Galal, A; Settin, A	1
Egawa, S; Fukui, H; Ichiba, M; Iijima, H; Inoue, A; Ishihara, R; Kishida, O; Kobayashi, I; Komori, M; Nishida, T; Ogawa, H; Oshita, M; Takeda, A; Takehara, T; Tanimura, H; Tsuji, S; Tsujii, M; Tsutsui, S; Uenoyama, N; Yasunaga, Y; Yoshio, T; Yura, M; Zushi, S	1
Kato, M	1
Akdoğan, RA; Bedir, R; Copur, A; Rakici, H; Yilmaz, A	1
Cho, KB; Ha, CY; Heo, J; Jang, BI; Jeon, SW; Jung, JT; Kim, ES; Kim, EY; Kim, HJ; Kwon, JG; Lee, DW; Lee, SH; Park, KS; Seo, HE	1
Akyon, Y; Bayrak, A; Celikel, C; Ertem, D; Kutluk, G; Tutar, E; Volkan, B	1
Chung, JW; Kim, KO; Kim, SY; Kim, YJ; Kwon, KA; Park, DK	1
Bae, SH; Hyun, MS; Jo, JC; Joo, YD; Kim, DY; Kim, H; Kim, HJ; Kim, MK; Lee, JH; Lee, KH; Lee, SM; Lee, WS; Ryoo, HM; Zang, DY	1
Mahachai, V; Siramolpiwat, S; Srinarong, C; Vilaichone, RK; Wongcha-um, A	1
Asaoka, D; Ito, M; Kawai, T; Kawakami, K; Kurihara, N; Masaoaka, T; Matsuhisa, T; Mine, T; Mizuno, S; Nagahara, A; Nishizawa, T; Ohkusa, T; Omata, F; Sakaki, N; Sasaki, H; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K; Torii, A	1
Akdogan, RA; Ayaz, T; Bedir, R; Rakici, H	1
Long, C; Zhang, S	1
Aydoğdu, S; Baran, M; Çakır, M; Tümgör, G; Yüksekkaya, HA	1
Hauser, G; JajacKnez, A; Salkic, N; Stimac, D; Vukelic, K	1
Hashimoto, Y; Hiki, N; Honda, M; Kamiya, S; Kumagai, K; Mine, S; Nunobe, S; Ohashi, M; Sano, T; Yamaguchi, T	1
Chen, Q; Graham, DY; Liang, X; Liu, W; Lu, H; Xiao, S; Zhang, W	1
Bair, MJ; Chang, CC; Chang, CY; Chang, WH; Chen, CC; Chen, MJ; Fang, YJ; Hsieh, CF; Hsu, YC; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Liou, TC; Liu, TY; Luo, JC; Shun, CT; Tsao, FY; Tseng, CH; Wu, JY; Wu, MS; Yang, TH	1
Chun, J; Kim, BG; Kim, BS; Kim, JS; Kim, JW; Koh, SJ; Lee, KL; Oh, B	1
Bilici, M; Demirci, H; Köktürk, F; Kurt, Ö; Öztürk, K; Üstündağ, Y; Uygun İlikhan, S; Uygun, A	1
Ahmed, MR; Mel-Hennawi, D	1
Durukan, E; Erhamamci, S; Gokturk, HS; Ozgur, GT; Unler, GK	1
Franceschi, F; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Lopetuso, LR; Ojetti, V; Petruzziello, C; Scaldaferri, F; Tortora, A	1
Bakshi, SS	1
Asaka, M; Funao, N; Murakami, K; Nishimura, A; Sakurai, Y; Shiino, M	1
Imamura, T; Imashuku, S; Ohmae, T; Osamura, T; Todo, K	1
Fukayama, M; Hayakawa, Y; Hirata, Y; Koike, K; Niikura, R; Shichijo, S; Ushiku, T; Yamada, A	1
Gotoda, T; Iwatsuka, K; Kusano, C; Moriyama, M; Suzuki, S	1
Ahmed, MR	1
Ida, A; Miyaki, A; Miyauchi, T; Yamaguchi, K	1
Inoue, H; Ito, M; Kasai, C; Moritani, I; Oya, Y; Shiraki, K; Sugimoto, K; Takase, K; Takei, Y; Tameda, M; Tanaka, J	1
Bair, MJ; Chang, CC; Chang, CY; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chen, YN; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Hu, WH; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Luo, JC; Sheu, BS; Shun, CT; Tseng, CH; Wu, JY; Wu, MS; Yang, TH	1
Fujisawa, T; Horiuchi, A; Imai, R; Kimura, T; Kiyosawa, K; Kubota, D; Maruyama, M; Matsuda, Y; Miyajima, M; Mori, H; Tanaka, N; Tokutake, K; Wada, S	1
Aktas, AH; Saridag, AM	1
Akay, S; Akpinar, Z; Unsal, B	1
Choi, IJ; Kim, BJ; Kim, JG; Kim, JI; Kim, JJ; Kim, SG; Lee, H; Lee, YC	1
Benedeto-Stojanov, D; Grgov, S; Radovanović-Dinić, B; Tasić, T	1
Coşkun, DÖ; Deniz, K; Gürsoy, Ş; Özbakir, Ö; Yagbasan, A; Yücesoy, M	1
Auesomwang, C; Chey, WD; Kiratisin, P; Leelakusolwong, S; Maneerattanaporn, M; Tanwandee, T	1
Robotis, J; Rokkas, T; Tsiodras, S	1
Irie, K; Kaneko, H; Kondo, M; Maeda, S; Sasaki, T; Shibata, W; Sue, S	1
Shahbazi, S; Vahdat Shariatpanahi, Z	1
Chu, CH; Liao, PH; Lin, YC; Liou, TC; Shih, SC	1
Ji, C; Li, L; Li, Y; Liu, J; Sun, Y; Wang, T; Yang, X; Zuo, X	1
Chayama, K; Kitadai, Y; Masaki, S; Matsuo, K; Matsuo, T; Naito, T; Sentani, K; Takigawa, H; Tanaka, S; Urabe, Y; Yuge, R	1
Baik, GH; Choi, IJ; Jeon, SW; Kim, BJ; Kim, GH; Kim, HS; Kim, HU; Kim, J; Kim, JG; Kim, JI; Kim, JJ; Kim, SG; Kim, SW; Lee, DH; Lee, H; Lee, J; Lee, JY; Lee, YC; Park, MI; Sung, JK; Yoon, SM	1
Bair, MJ; Chang, CM; Chang, CY; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chen, YN; Chuang, EY; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Lee, JY; Lin, JT; Liou, JM; Lu, TP; Luo, JC; Wu, JY; Wu, MS; Yang, TH	1
Asahina, A; Kikuchi, S; Nobeyama, Y; Saeki, H	1
Jeon, SW; Kwon, YH; Lee, HS; Lee, SW; Nam, SY	1
Choi, IJ; Joo, J; Kim, CG; Kim, YI; Kook, MC; Lee, JY; Park, B	1
Mukhopadhyay, AK; Nandi, SP; Saxena, A	1
Fukuda, K; Fukuda, M; Hirashita, Y; Kawahara, Y; Kodama, M; Kudo, Y; Matsunari, O; Mizukami, K; Murakami, K; Ogawa, R; Okamoto, K; Okimoto, T; Wada, Y	1
Bhatia, S; Chung, H; Huh, KY; Kim, YK; Lee, S; Nakaya, R; Takanami, Y; Yu, KS	1
Chiu, CT; Chong, CF; Chung, WC; Gu, L; Hou, X; Kudou, K; Meng, F; Sha, W; Wang, J; Zhang, S	1
Chey, WD; Howden, CW; Hunt, BJ; Laine, L; López, LJ; Mégraud, F	1
Ding, YM; Han, ZX; Ji, R; Li, YY; Lin, BS; Zhang, WL	1

Reviews

53 review(s) available for lansoprazole and clarithromycin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Diagnosis and treatment of Helicobacter pylori]. Nihon Ika Daigaku zasshi, 1997, Volume: 64, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Bacteriological Techniques; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Polymerase Chain Reaction; Ranitidine	1997
Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review. Helicobacter, 1997, Volume: 2, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Ranitidine	1997
Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis. Helicobacter, 1998, Volume: 3, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Selection; Penicillins; Peptic Ulcer; Randomized Controlled Trials as Topic	1998
[Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy]. Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors	1999
[Lansoprazole: a review of its role in Helicobacter pylori eradication therapy]. Revista espanola de enfermedades digestivas, 1999, Volume: 91, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Nitroimidazoles; Omeprazole; Penicillins	1999
[Recent guidelines for the management of Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors	2001
[A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Patient Compliance; Polymorphism, Genetic; Proton Pump Inhibitors; Treatment Failure	2001
[Progress of tailor-made treatment of peptic ulcer]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors	2002
[The outline of medical treatment of peptic ulcer]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Misoprostol; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors	2002
[Guidelines for the management of Helicobacter pylori infection in Japan]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Omeprazole; Practice Guidelines as Topic	2002
[New triple therapy for Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors	2002
[Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Tetracycline	2002
[Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Failure; Treatment Outcome	2002
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pharmacogenetics; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure	2002
[Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Diterpenes; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Treatment Outcome	2002
[Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Failure	2002
[Adverse effects of H. pylori eradication therapy and its measure]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Diarrhea; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Lansoprazole; Mouth Diseases; Omeprazole; Skin Diseases	2002
[H. pylori eradication therapy and natural history of peptic ulcer]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Secondary Prevention	2002
[Peptic ulcer in the elderly]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors	2002
[Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Depression, Chemical; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors	2002
[Plaunotol]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Resistance, Bacterial; Drug Therapy, Combination; Fatty Alcohols; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Neutrophil Activation; Omeprazole; Peptic Ulcer; Prognosis	2002
[Polaprezinc]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Ulcer Agents; Carnosine; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Urease; Zinc Compounds	2002
[Helicobacter heilmannii-associated gastritis]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline	2002
[Practice guidelines for diagnosis and treatment of Helicobacter pylori infections and their application in clinical practice]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2002, Mar-20, Volume: 91 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors	2002
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome	2002
[Eradication therapy of Helicobacter pylori for elderly patients in Japan]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Omeprazole; Practice Guidelines as Topic	2002
[New triple therapy for Helicobacter pylori infection in Japan]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole	2003
Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy. British journal of haematology, 2003, Volume: 120, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Stomach Neoplasms; Thyroid Neoplasms; Thyroiditis, Autoimmune	2003
[Guidelines in the management of Helicobacter pylori infection in Japan]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Microbiology; Omeprazole; Peptic Ulcer; Polyps; Practice Guidelines as Topic; Proton Pump Inhibitors; Societies, Medical; Stomach Neoplasms	2003
How can the current strategies for Helicobacter pylori eradication therapy be improved? Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2003, Volume: 17 Suppl B Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Time Factors	2003
Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease. The Keio journal of medicine, 2003, Volume: 52, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Apoptosis; Chemistry, Clinical; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Japan; Lansoprazole; Omeprazole; Peptic Ulcer; Urease	2003
[Eradication effect of lansoprazole-based triple therapy against H. pylori]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Stomach Ulcer	2004
[Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2004, Volume: 101, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Purpura, Thrombocytopenic, Idiopathic	2004
Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature. Journal of gastroenterology, 2005, Volume: 40, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter heilmannii; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole	2005
Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies. Drug metabolism and pharmacokinetics, 2005, Volume: 20, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Gastroesophageal Reflux; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole	2005
[Guidelines in the management of H. pylori infection in Japan]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors	2005
[Cap polyposis and Helicobacter pylori]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Intestinal Polyposis; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Treatment Outcome	2005
[Concomitant dosing of a H2 receptor antagonist (H2RA) with a triple therapy increases the cure rate of Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic	2005
[Triple therapy for eradication of Helicobacter pylori in Japan]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Humans; Insurance, Health; Japan; Lansoprazole; Omeprazole; Patient Compliance; Practice Guidelines as Topic; Proton Pump Inhibitors	2005
[Adverse effects of Helicobacter pylori eradication and its prevention]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors	2005
[Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Treatment Outcome	2005
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure	2005
[Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Time Factors; Treatment Outcome	2005
[Investigation about 3rd line eradication of H. pylori]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ampicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure	2005
[Helicobacter pylori eradication therapy for children]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome	2005
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dialysis; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors	2005
[Helicobacter pylori infection and probiotics]. Nihon saikingaku zasshi. Japanese journal of bacteriology, 2007, Volume: 62, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Bifidobacterium; Clarithromycin; Clostridium butyricum; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus; Lansoprazole; Probiotics; Saccharomyces	2007
[Regression of MALT lymphoma of the rectum after Helicobacter pylori eradication therapy in a patient negative for Helicobacter pylori]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2010, Volume: 107, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Rectal Neoplasms	2010
[Expanded indication of National Health Insurance for H. pylori associated gastritis]. Nihon rinsho. Japanese journal of clinical medicine, 2014, Volume: 72, Issue:5 Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; National Health Programs; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Neoplasms	2014
Doxycycline in Eradication Therapy of Helicobacter pylori--a Systematic Review and Meta-Analysis. Digestion, 2016, Volume: 93, Issue:2 Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Proton Pump Inhibitors; Ranitidine; Tetracycline	2016
Journal of biosciences, 2020, Volume: 45 Topics: Amoxicillin; Anti-Bacterial Agents; Biological Products; Bismuth; Clarithromycin; Drug Therapy, Combination; Dysbiosis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Phytochemicals; Plant Extracts; Plants, Medicinal; Probiotics	2020
Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis. Digestion, 2023, Volume: 104, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Pyrroles; Treatment Outcome	2023

Trials

226 trial(s) available for lansoprazole and clarithromycin

Article	Year
Efficacy of lansoprazole in eradication of Helicobacter pylori. Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer	1995
Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients. Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Recurrence; Stomach Ulcer	1995
Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients. Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Fatty Alcohols; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Recurrence; Stomach Ulcer	1995
Eradication of Helicobacter pylori with lansoprazole and clarithromycin. Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole	1995
Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Digestive diseases and sciences, 1995, Volume: 40, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Cell Division; Clarithromycin; Drug Therapy, Combination; Epithelium; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole	1995
Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication? The American journal of gastroenterology, 1995, Volume: 90, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Time Factors	1995
Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori. European journal of gastroenterology & hepatology, 1995, Volume: 7 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer	1995
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1996, Volume: 47, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Tinidazole	1996
Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline	1996
Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients. Journal of gastroenterology, 1996, Volume: 31 Suppl 9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Pepsin A; Protease Inhibitors; Stomach Ulcer	1996
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors	1996
Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance	1996
Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer. The American journal of gastroenterology, 1997, Volume: 92, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Single-Blind Method; Time Factors	1997
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. The American journal of gastroenterology, 1997, Volume: 92, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Dyspepsia; Evaluation Studies as Topic; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Medical Records; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Taste Disorders	1997
Triple therapy with lansoprazole, clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: a short report. Helicobacter, 1996, Volume: 1, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome	1996
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. Helicobacter, 1996, Volume: 1, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Eruptions; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hypertension; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prevalence; Proton Pump Inhibitors; Research Design; Treatment Outcome	1996
Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report. Helicobacter, 1996, Volume: 1, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Clarithromycin; Diarrhea; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Safety; Taste Disorders; Treatment Outcome	1996
Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori. Helicobacter, 1996, Volume: 1, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohol Drinking; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenitis; Esophagitis; Female; Helicobacter Infections; Helicobacter pylori; Hernia, Hiatal; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Smoking; Treatment Outcome	1996
The efficacy and safety of one-week triple therapy with lansoprazole, clarithromycin, and metronidazole for the treatment of Helicobacter pylori infection in Japanese patients. Helicobacter, 1997, Volume: 2, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole	1997
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance. The American journal of gastroenterology, 1998, Volume: 93, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Ranitidine; Tetracycline	1998
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut, 1997, Volume: 41, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method	1997
A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. The American journal of gastroenterology, 1998, Volume: 93, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Tinidazole; Treatment Outcome	1998
Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy. Scandinavian journal of gastroenterology, 1998, Volume: 33, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Recurrence; Vagotomy	1998
Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough? Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Diarrhea; Drug Therapy, Combination; Endoscopes; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Taste Disorders; Time Factors; Treatment Outcome	1998
Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anus Diseases; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Diarrhea; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hallucinations; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nausea; Omeprazole; Peptic Ulcer; Pregnancy; Protein Synthesis Inhibitors; Proton Pump Inhibitors; Taste Disorders; Time Factors; Tongue Diseases; Treatment Outcome; Urea; Vomiting	1998
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. The American journal of gastroenterology, 1998, Volume: 93, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillins; Recurrence	1998
[Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection]. Zhonghua nei ke za zhi, 1996, Volume: 35, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Organometallic Compounds	1996
Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Stomach Ulcer	1998
Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pefloxacin; Proton Pump Inhibitors	1998
[Eradication therapies for Helicobacter pylori]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1998, Volume: 72, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Tinidazole	1998
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Treatment Outcome	1998
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study. The American journal of gastroenterology, 1998, Volume: 93, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer	1998
Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome	1998
Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine; Time Factors; Tinidazole	1998
Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Annals of internal medicine, 1998, Nov-01, Volume: 129, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Female; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Immunoglobulin G; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Polyps; Proton Pump Inhibitors; Single-Blind Method; Statistics, Nonparametric; Stomach Neoplasms	1998
Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children. Helicobacter, 1998, Volume: 3, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Treatment Outcome	1998
[Previous treatment with omeprazole and H. pylori: does it diminish the eradication efficacy of the "new" triple therapies of one week's duration?]. Medicina clinica, 1998, Nov-28, Volume: 111, Issue:18 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Odds Ratio; Omeprazole; Penicillins; Prognosis; Prospective Studies; Time Factors	1998
[Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer]. Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline; Treatment Outcome	1999
[A comparative study; one week treatment versus two weeks treatment with lansoprazol, amoxycillin and clarythromycin for the eradication of Helicobacter pylori in patient with gastric and duodenal ulcer]. Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Treatment Outcome	1999
[Triple therapy regimens involving H2 blockaders for therapy of Helicobacter pylori infections]. Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Treatment Outcome	1999
Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Organometallic Compounds	1999
Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population. Journal of gastroenterology and hepatology, 1999, Volume: 14, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Time Factors	1999
Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Carnosine; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Penicillins; Prospective Studies; Protective Agents; Zinc Compounds	1999
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Single-Blind Method; Treatment Outcome	1999
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients. Journal of gastroenterology and hepatology, 1999, Volume: 14, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome	1999
Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole	1999
Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome	1999
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Ranitidine; Treatment Outcome	1999
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed. Journal of clinical gastroenterology, 1999, Volume: 29, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Proton Pump Inhibitors; Salicylates; Treatment Outcome	1999
Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases. Helicobacter, 1999, Volume: 4, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome	1999
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. The American journal of physiology, 1999, Volume: 277, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Esophagitis; Female; Food; Gastric Acid; Gastric Emptying; Gastric Mucosa; Gastrins; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Monitoring, Physiologic; Omeprazole; Penicillins; Polyethylene Glycols; Postprandial Period; Solvents	1999
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Asia; Breath Tests; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Risk Factors; Urea	2000
Influence of oral Helicobacter pylori on the success of eradication therapy against gastric Helicobacter pylori. Helicobacter, 2000, Volume: 5, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Dental Plaque; DNA, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Mouth Mucosa; Omeprazole; Polymerase Chain Reaction; Saliva; Sensitivity and Specificity; Treatment Outcome; Urease	2000
Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole. Digestive diseases and sciences, 2000, Volume: 45, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole	2000
Once-daily Helicobacter pylori treatment to family members of gastric cancer patients. The American journal of gastroenterology, 2000, Volume: 95, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Family; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Stomach Neoplasms	2000
Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ornidazole; Penicillins; Peptic Ulcer; Treatment Outcome	2000
A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection. Journal of pediatric gastroenterology and nutrition, 2000, Volume: 30, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Lansoprazole; Male; Omeprazole; Prospective Studies	2000
Pharmacokinetics of clarithromycin in Helicobacter pylori eradication therapy in patients with liver cirrhosis. Alimentary pharmacology & therapeutics, 2000, Volume: 14 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer	2000
Helicobacter pylori eradication with lansoprazole, amoxycillin and clarithromycin: testing an ideal regimen in a multicultural south east Asian population and examining factors potentially influencing eradication. Australian and New Zealand journal of medicine, 2000, Volume: 30, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; China; Clarithromycin; Drug Therapy, Combination; Ethnicity; Female; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Likelihood Functions; Logistic Models; Malaysia; Male; Middle Aged; Omeprazole; Prospective Studies; Singapore	2000
Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India. Helicobacter, 2000, Volume: 5, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins	2000
[Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers]. Gastroenterologie clinique et biologique, 2000, Volume: 24, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins	2000
Comparison of the efficacy of 400mg and 800mg of clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection in a Japanese population. Journal of gastroenterology, 2000, Volume: 35, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Omeprazole; Penicillins; Prospective Studies; Sensitivity and Specificity	2000
[Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer]. Orvosi hetilap, 2000, Jul-30, Volume: 141, Issue:31 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Treatment Outcome	2000
Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy. Journal of the Formosan Medical Association = Taiwan yi zhi, 2000, Volume: 99, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prospective Studies; Treatment Outcome	2000
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens. The American journal of gastroenterology, 2000, Volume: 95, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aminopyrine; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Radioisotopes; Clarithromycin; Cytochrome P-450 Enzyme Inhibitors; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides	2000
Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer. Journal of clinical gastroenterology, 2001, Volume: 32, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Lansoprazole; Male; Middle Aged; Omeprazole; Sensitivity and Specificity; Tinidazole	2001
A short-term eradication therapy for Helicobacter pylori acute gastritis. Journal of gastroenterology and hepatology, 2000, Volume: 15, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Quinolones; Stomach; Time Factors	2000
[Usefulness of new triple therapy containing PPI]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors	2001
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? The American journal of gastroenterology, 2001, Volume: 96, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Omeprazole; Prognosis; Prospective Studies; Proton Pump Inhibitors; Time Factors	2001
Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clinical pharmacology and therapeutics, 2001, Volume: 69, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Duodenal Ulcer; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Treatment Outcome	2001
The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. The Israel Medical Association journal : IMAJ, 2001, Volume: 3, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Patient Selection; Penicillins; Peptic Ulcer; Time Factors; Treatment Failure	2001
Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans. Microscopy research and technique, 2001, Jun-01, Volume: 53, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Clarithromycin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Electrophoresis, Polyacrylamide Gel; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Isoenzymes; Lansoprazole; Membrane Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Omeprazole; Prostaglandin-Endoperoxide Synthases	2001
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Treatment Outcome	2001
Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study. Clinical therapeutics, 2001, Volume: 23, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Headache; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pruritus; Ranitidine; Recurrence; Taste Disorders; Tinidazole; Treatment Outcome	2001
Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet (London, England), 2001, Jun-02, Volume: 357, Issue:9270 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Recurrence; Treatment Outcome	2001
Quadruple therapy for symptomatic spontaneous duodenal ulcer disease. Postgraduate medical journal, 2001, Volume: 77, Issue:909 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Tetracycline	2001
Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection. How long should it be given? Scandinavian journal of gastroenterology, 2001, Volume: 36, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Polymerase Chain Reaction; Time Factors	2001
Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Diterpenes; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Pepsin A; Prospective Studies; Treatment Outcome; Urea; Urease	2001
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. The American journal of gastroenterology, 2001, Volume: 96, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absenteeism; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Health Status; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Satisfaction; Penicillins; Referral and Consultation	2001
Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2000, Volume: 32, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome	2000
A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy. Digestive diseases (Basel, Switzerland), 2001, Volume: 19, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors	2001
A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 1999, Volume: 32, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies	1999
Efficacy of a nitroimidazole containing tripletherapy regime in Singapore. Singapore medical journal, 2001, Volume: 42, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nitroimidazoles; Omeprazole; Singapore; Tinidazole	2001
A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter, 2001, Volume: 6, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Omeprazole; Peptic Ulcer	2001
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). Archives of internal medicine, 2002, Jan-28, Volume: 162, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Regression Analysis; Treatment Outcome	2002
Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin. Acta medica (Hradec Kralove), 2001, Volume: 44, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antioxidants; Ascorbic Acid; beta Carotene; Clarithromycin; Disulfides; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Sulfinic Acids	2001
Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients. The Journal of dermatology, 2002, Volume: 29, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Child; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Lansoprazole; Male; Middle Aged; Omeprazole; Skin Diseases; Treatment Outcome	2002
Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Costs; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome	2002
Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Taiwan	2002
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Combinations; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Moxifloxacin; Omeprazole; Patient Compliance; Quinolines; Treatment Outcome	2002
[Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactams; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome	2002
Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastroesophageal Reflux; Helicobacter Infections; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Quality of Life; Urea	2002
Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype. Journal of gastroenterology and hepatology, 2002, Volume: 17, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; DNA; Drug Therapy, Combination; Enzyme Inhibitors; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome	2002
Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol. Clinical pharmacology and therapeutics, 2002, Volume: 72, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrocortisone; Lansoprazole; Liver Function Tests; Male; Middle Aged; Omeprazole; Oxidoreductases, N-Demethylating; Penicillins; Protein Synthesis Inhibitors	2002
Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Bifidobacterium; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Probiotics; Yogurt	2002
Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. The American journal of gastroenterology, 2002, Volume: 97, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Prospective Studies; Stomach Diseases	2002
Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer	2002
Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Area Under Curve; Clarithromycin; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Humans; Lansoprazole; Male; Omeprazole	2002
The effects of nocturnal acid breakthrough on Helicobacter pylori eradication. Helicobacter, 2002, Volume: 7, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Circadian Rhythm; Clarithromycin; Drug Therapy, Combination; Female; Gastric Acid; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Treatment Outcome	2002
Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients. Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Family Health; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Stomach Neoplasms; Tablets; Treatment Outcome	2003
Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin. Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Cytochrome P-450 Enzyme System; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome	2003
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan. European journal of gastroenterology & hepatology, 2003, Volume: 15, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure; Treatment Outcome	2003
[New triple therapy for Helicobacter pylori infection in Japan]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole	2003
Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori. Helicobacter, 2003, Volume: 8, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Piperidines; Prospective Studies; Pyridines	2003
Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Journal of gastroenterology, 2003, Volume: 38, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome	2003
The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency. Alimentary pharmacology & therapeutics, 2003, May-15, Volume: 17, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Lansoprazole; Male; Middle Aged; Omeprazole; Treatment Outcome	2003
Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment. Alimentary pharmacology & therapeutics, 2003, Jul-01, Volume: 18, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tinidazole; Treatment Outcome	2003
Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers. World journal of gastroenterology, 2003, Volume: 9, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Wound Healing	2003
Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia. Alimentary pharmacology & therapeutics, 2003, Sep-15, Volume: 18, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome	2003
Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia. The American journal of gastroenterology, 2003, Volume: 98, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Probability; Reference Values; Severity of Illness Index; Treatment Outcome	2003
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial. Alimentary pharmacology & therapeutics, 2003, Oct-15, Volume: 18, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Peptic Ulcer; Secondary Prevention; Treatment Outcome	2003
Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection. The American journal of gastroenterology, 2003, Volume: 98, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1; Lansoprazole; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Multivariate Analysis; Omeprazole; Polymorphism, Genetic; Probability; Proton Pump Inhibitors; Proton Pumps; Rabeprazole; Statistics, Nonparametric; Treatment Outcome	2003
Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2004, Volume: 2, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antibody Specificity; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Genetic Predisposition to Disease; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Omeprazole; Patient Compliance; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Proton Pumps; Treatment Outcome	2004
[Eradication effect of lansoprazole-based triple therapy against H. pylori]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Stomach Ulcer	2004
Helicobacter pylori eradication: efficacy of conventional therapy in India. Tropical doctor, 2004, Volume: 34, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Tinidazole; Treatment Outcome	2004
Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity. Journal of gastroenterology and hepatology, 2004, Volume: 19, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Peptic Ulcer; Prospective Studies; Tinidazole; Treatment Outcome; Wound Healing	2004
Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. World journal of gastroenterology, 2004, Jun-01, Volume: 10, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome	2004
The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2004, Jun-15, Volume: 19, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Tinidazole; Treatment Outcome	2004
In treatment of active duodenal ulcer and Helicobacter pylori eradication. Hepato-gastroenterology, 2003, Volume: 50 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome	2003
Helicobacter pylori eradication decreases blood neutrophil and monocyte counts. Alimentary pharmacology & therapeutics, 2004, Volume: 20 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Leukocyte Count; Leukocytes, Mononuclear; Male; Middle Aged; Neutrophils; Omeprazole; Peptic Ulcer; Retrospective Studies	2004
The effect of Helicobacter pylori eradication on gastroesophageal reflux disease. Journal of clinical gastroenterology, 2004, Volume: 38, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopes, Gastrointestinal; Female; Gastroesophageal Reflux; Heartburn; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Monitoring, Physiologic; Omeprazole; Treatment Outcome; Urease	2004
Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection. Wiener klinische Wochenschrift, 2004, Jul-31, Volume: 116, Issue:14 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Care Management; Treatment Outcome	2004
Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Archives of internal medicine, 2004, Sep-27, Volume: 164, Issue:17 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic	2004
Effects of the association of lansoprazole, clarithromycin and metronidazole for helicobacter Pylori eradication therapy, measured by the 13C Aminopyrine breath test. Medical science monitor : international medical journal of experimental and clinical research, 2005, Volume: 11, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Aminopyrine; Breath Tests; Carbon Isotopes; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Sex Characteristics	2005
Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial. World journal of gastroenterology, 2005, Feb-21, Volume: 11, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Recurrence; Wound Healing	2005
Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes. British journal of clinical pharmacology, 2005, Volume: 59, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP2C19; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Female; Genotype; Heterozygote; Homozygote; Humans; Lansoprazole; Male; Mixed Function Oxygenases; Omeprazole; Protein Synthesis Inhibitors; Proton Pump Inhibitors	2005
First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens. Alimentary pharmacology & therapeutics, 2005, Mar-15, Volume: 21, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Ranitidine; Risk Factors	2005
Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes. Chirality, 2005, Volume: 17, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dexlansoprazole; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Genotype; Heterozygote; Homozygote; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Proton Pump Inhibitors; Stereoisomerism	2005
Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial. Alimentary pharmacology & therapeutics, 2005, May-15, Volume: 21, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Esophagitis, Peptic; Follow-Up Studies; Heartburn; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Risk Assessment; Single-Blind Method	2005
Quality of gastric ulcer healing evaluated by endoscopic ultrasonography. World journal of gastroenterology, 2005, Jun-14, Volume: 11, Issue:22 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endosonography; Female; Helicobacter Infections; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Stomach Ulcer; Wound Healing	2005
Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura. Annals of hematology, 2005, Volume: 84, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Remission Induction; Treatment Outcome	2005
A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Nov-01, Volume: 41, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prevalence; Prospective Studies; Risk Factors; Treatment Failure	2005
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2004, Volume: 15, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Single-Blind Method; Sulfoxides; Treatment Outcome	2004
Effect of N-acetyl cysteine on Helicobacter pylori. Southern medical journal, 2005, Volume: 98, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Expectorants; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Stomach Diseases	2005
[H. pylori eradication package set (Lansap)]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Packaging; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome	2005
[Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Tranexamic Acid; Treatment Outcome	2005
Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study. The American journal of gastroenterology, 2005, Volume: 100, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Needs Assessment; Omeprazole; Peptic Ulcer; Probability; Reference Values; Rheumatic Diseases; Risk Assessment; Statistics, Nonparametric; Treatment Outcome	2005
Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study. Digestive diseases and sciences, 2006, Volume: 51, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Biopsy; Brazil; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prevalence; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome	2006
Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. World journal of gastroenterology, 2006, Mar-21, Volume: 12, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Middle Aged; Omeprazole; Organometallic Compounds; Polyps; Proton Pump Inhibitors; Stomach Neoplasms; Tinidazole	2006
Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection. Helicobacter, 2006, Volume: 11, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clinical Protocols; Combined Modality Therapy; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Middle Aged; Omeprazole; Proportional Hazards Models; Research Design; Sample Size; Stomach Neoplasms	2006
A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide. Journal of gastroenterology and hepatology, 2006, Volume: 21, Issue:1 Pt 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Pilot Projects; Quinolones; Stomach Ulcer; Treatment Outcome	2006
Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve. Therapeutic drug monitoring, 2006, Volume: 28, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Double-Blind Method; Drug Synergism; Enzyme Inhibitors; Female; Fluvoxamine; Genotype; Humans; Lansoprazole; Male; Mixed Function Oxygenases; Omeprazole	2006
Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy. World journal of gastroenterology, 2006, Jun-28, Volume: 12, Issue:24 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pilot Projects; Prospective Studies; Rural Population	2006
Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study. Journal of gastroenterology, 2006, Volume: 41, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Cisapride; Clarithromycin; Domperidone; Dopamine Antagonists; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Treatment Outcome	2006
Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection. Helicobacter, 2006, Volume: 11, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Famotidine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Middle Aged; Proton Pump Inhibitors; Proton Pumps; Treatment Failure	2006
Pharmacoeconomic comparison of Helicobacter pylori eradication regimens. Pharmacy world & science : PWS, 2006, Volume: 28, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Melena; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Taste Disorders; Time Factors; Treatment Outcome	2006
Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. International journal of antimicrobial agents, 2007, Volume: 29, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bifidobacterium; Cell Count; Clarithromycin; Combined Modality Therapy; Double-Blind Method; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Lacticaseibacillus rhamnosus; Lansoprazole; Male; Middle Aged; Probiotics; Propionibacterium; Treatment Outcome	2007
Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori. Clinical pharmacology and therapeutics, 2007, Volume: 81, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Costs and Cost Analysis; Cytochrome P-450 CYP2C19; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Mixed Function Oxygenases; Pharmacogenetics; Polymorphism, Genetic; RNA, Ribosomal	2007
Effect of Helicobacter pylori infection and acid blockade by lansoprazole on clarithromycin bioavailability. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2007, Volume: 40, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Area Under Curve; Biological Availability; Case-Control Studies; Chromatography, High Pressure Liquid; Clarithromycin; Cross-Over Studies; Drug Synergism; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Proton Pump Inhibitors; Time Factors	2007
Eradication of Helicobacter pylori in hemodialysis patients. Renal failure, 2007, Volume: 29, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Lansoprazole; Male; Middle Aged; Renal Dialysis	2007
Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan. Hepato-gastroenterology, 2007, Volume: 54, Issue:74 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Phenotype; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Retreatment; Stomach Diseases; Treatment Outcome	2007
Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection. World journal of gastroenterology, 2007, Jul-28, Volume: 13, Issue:28 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Piperidines; Pyridines	2007
Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study. Helicobacter, 2007, Volume: 12, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nausea; Probiotics; Prospective Studies; Saccharomyces; Stomach Diseases; Treatment Outcome	2007
Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy. Helicobacter, 2007, Volume: 12, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Female; Gastric Acid; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Treatment Outcome	2007
Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy. Helicobacter, 2007, Volume: 12, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Constipation; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Nausea; Ofloxacin; Treatment Outcome; Vomiting	2007
Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial. Journal of gastroenterology, 2007, Volume: 42, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Prevalence; Proton Pump Inhibitors; Quinolones; Retrospective Studies; Stomach Ulcer; Treatment Outcome	2007
The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori. Journal of digestive diseases, 2007, Volume: 8, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Middle Aged; Single-Blind Method; Statistics, Nonparametric; Tetracycline; Treatment Outcome	2007
Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers. European journal of clinical pharmacology, 2008, Volume: 64, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dexlansoprazole; Double-Blind Method; Female; Fluvoxamine; Genotype; Half-Life; Humans; Lansoprazole; Male; Models, Biological; Proton Pump Inhibitors; Stereoisomerism	2008
Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital. World journal of gastroenterology, 2008, Jun-28, Volume: 14, Issue:24 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitals, General; Hospitals, Rural; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Prospective Studies; Tetracycline; Treatment Outcome	2008
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet (London, England), 2008, Aug-02, Volume: 372, Issue:9636 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Infective Agents; Clarithromycin; Endoscopy, Gastrointestinal; Endpoint Determination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms	2008
Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial. Alimentary pharmacology & therapeutics, 2008, Dec-01, Volume: 28, Issue:11-12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; Dyspepsia; Follow-Up Studies; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Proton Pump Inhibitors; Quality of Life; Treatment Outcome; United Kingdom	2008
Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study. Annals of hematology, 2009, Volume: 88, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adrenal Cortex Hormones; Adult; Aged; Amoxicillin; Clarithromycin; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Platelet Count; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Remission Induction; Time Factors; Treatment Outcome	2009
Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea. Helicobacter, 2008, Volume: 13, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Lansoprazole; Male; Middle Aged; Piperidines; Pyridines; Time Factors; Treatment Outcome	2008
Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial. Helicobacter, 2008, Volume: 13, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antigens, Bacterial; Child; Child, Preschool; Clarithromycin; Double-Blind Method; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Stomach; Vietnam	2008
Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study. Helicobacter, 2008, Volume: 13, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Iatrogenic Disease; Lansoprazole; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome	2008
Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment. The American journal of the medical sciences, 2009, Volume: 338, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Tetracycline; Treatment Outcome; Young Adult	2009
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? World journal of gastroenterology, 2009, Sep-14, Volume: 15, Issue:34 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Stomach Neoplasms; Young Adult	2009
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome	2010
Does pretreatment with lansoprazole influence Helicobacter pylori eradication rate and quality of life? Digestion, 2010, Volume: 81, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Proton Pump Inhibitors; Quality of Life; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Stomach Ulcer; Treatment Outcome	2010
Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori. Journal of medicinal food, 2011, Volume: 14, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Cultured Milk Products; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged	2011
Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels. Mediators of inflammation, 2010, Volume: 2010 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Arginine; Atherosclerosis; Cardiovascular Abnormalities; Clarithromycin; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nitric Oxide Synthase Type III; Young Adult	2010
Comparison of two different treatment protocols in Helicobacter pylori eradication. Southern medical journal, 2011, Volume: 104, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Tetracycline; Turkey	2011
Triple therapy with ecabet sodium, amoxicillin and lansoprazole for 2 weeks as the rescue regimen for H. pylori infection. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Failure	2011
Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2011, Volume: 30, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Ammonia; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hepatic Encephalopathy; Humans; Lansoprazole; Liver Cirrhosis; Male; Psychometrics; Tinidazole	2011
A new modified concomitant therapy for Helicobacter pylori eradication in Turkey. Helicobacter, 2011, Volume: 16, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Treatment Outcome; Young Adult	2011
Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea. British journal of clinical pharmacology, 2012, Volume: 73, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Republic of Korea; Treatment Outcome	2012
Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori. Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; Clarithromycin; Combined Modality Therapy; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Male; Middle Aged; Outpatient Clinics, Hospital; Proton Pump Inhibitors; Turkey; Vitamin E	2012
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet (London, England), 2011, Aug-06, Volume: 378, Issue:9790 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Latin America; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Time Factors; Treatment Outcome; Urea	2011
A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. The American journal of gastroenterology, 2011, Volume: 106, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Levofloxacin; Male; Middle Aged; Nitro Compounds; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Recurrence; Thiazoles; Young Adult	2011
Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication. Journal of digestive diseases, 2012, Volume: 13, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome	2012
Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy. Journal of clinical gastroenterology, 2013, Volume: 47, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Algorithms; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome	2013
Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance. Helicobacter, 2012, Volume: 17, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Vietnam	2012
Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chi-Square Distribution; Clarithromycin; Confidence Intervals; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Male; Metronidazole; Middle Aged; Patient Compliance; Republic of Korea; Urea	2012
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet (London, England), 2013, Jan-19, Volume: 381, Issue:9862 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Ofloxacin	2013
Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour: a prospective, randomized, placebo-controlled multi-centre trial. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2013, Volume: 45, Issue:5 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iatrogenic Disease; Lansoprazole; Male; Middle Aged; Prospective Studies; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome	2013
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. JAMA, 2013, Feb-13, Volume: 309, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Humans; Lansoprazole; Latin America; Male; Medication Adherence; Metronidazole; Middle Aged; Primary Prevention; Recurrence; Risk; Stomach Neoplasms; Young Adult	2013
[Is sequential eradication of Helicobacter pylori effective? Sequential treatment more effective than triple therapy in patients with clarithromycin resistance]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:13 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Peptic Ulcer; Stomach Neoplasms; Taiwan	2013
Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects β-catenin distribution. Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Jul-15, Volume: 19, Issue:14 Topics: Adenocarcinoma, Mucinous; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; beta Catenin; Cell Membrane; Cell Nucleus; Clarithromycin; Combined Modality Therapy; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization; Lansoprazole; Middle Aged; Peritoneal Neoplasms; Protein Transport; Pseudomyxoma Peritonei; Treatment Outcome	2013
Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimens. The Kaohsiung journal of medical sciences, 2013, Volume: 29, Issue:7 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenoscopy; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole	2013
The efficacy of two-week quadruple first-line therapy with bismuth, lansoprazole, amoxicillin, clarithromycin on Helicobacter pylori eradication: a prospective study. Helicobacter, 2013, Volume: 18, Issue:6 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Young Adult	2013
A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2013, Volume: 24, Issue:4 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Treatment Outcome; Young Adult	2013
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. Digestive diseases and sciences, 2014, Volume: 59, Issue:8 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Contraindications; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Nickel; Pilot Projects	2014
Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan. World journal of gastroenterology, 2014, Apr-21, Volume: 20, Issue:15 Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Humans; Japan; Lansoprazole; Male; Middle Aged; Prospective Studies; Time Factors; Young Adult	2014
Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates. Journal of digestive diseases, 2014, Volume: 15, Issue:9 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Treatment Outcome; Young Adult	2014
The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2015, Volume: 159, Issue:2 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Blood Glucose; Clarithromycin; Drug Therapy, Combination; Female; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Homeostasis; Humans; Insulin Resistance; Lansoprazole; Male; Prospective Studies; Single-Blind Method	2015
A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2014, Volume: 46, Issue:11 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Metronidazole; Middle Aged; Multivariate Analysis; Prospective Studies; Republic of Korea; Time Factors; Treatment Outcome	2014
Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains? European journal of gastroenterology & hepatology, 2014, Volume: 26, Issue:11 Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Treatment Outcome	2014
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia. Annals of hematology, 2015, Volume: 94, Issue:5 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia; Treatment Outcome; Young Adult	2015
Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:22 Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Organometallic Compounds; Probiotics; Prognosis; Prospective Studies; Salicylates; Thailand	2014
Comparison of levofloxacin- and moxifloxacin-based triple therapies with standard treatment in eradication of Helicobacter pylori as first-line therapy. Digestion, 2014, Volume: 90, Issue:4 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Treatment Outcome; Young Adult	2014
Comparison of standard and standard plus vitamin E therapy for Helicobacter pylori eradications in children. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2014, Volume: 25 Suppl 1 Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Antioxidants; Breath Tests; Child; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Prospective Studies; Proton Pump Inhibitors; Vitamin E	2014
Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial. Medicine, 2015, Volume: 94, Issue:17 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bifidobacterium; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lacticaseibacillus rhamnosus; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Placebos; Probiotics; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome	2015
Preoperative vs Postoperative Eradication of Helicobacter pylori in 150 Patients with Gastric Cancer: A Randomized Controlled Trial. Journal of the American College of Surgeons, 2015, Volume: 221, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Postoperative Care; Preoperative Care; Proton Pump Inhibitors; Stomach Neoplasms; Treatment Outcome	2015
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy. Gut, 2015, Volume: 64, Issue:11 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Young Adult	2015
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Gut, 2016, Volume: 65, Issue:11 Topics: Adult; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hospitalization; Humans; Lansoprazole; Male; Metronidazole; Proton Pump Inhibitors; Treatment Outcome	2016
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial. Helicobacter, 2016, Volume: 21, Issue:3 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Ribosomal; Drug Therapy, Combination; Female; Gastritis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Lansoprazole; Male; Middle Aged; Peptic Ulcer; Probiotics; Proton Pump Inhibitors; Sequence Analysis, DNA; Stomach Neoplasms	2016
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion. The Journal of laryngology and otology, 2015, Volume: 129, Issue:11 Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Case-Control Studies; Child; Child, Preschool; Chronic Disease; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Otitis Media with Effusion; Proton Pump Inhibitors; Treatment Outcome	2015
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Gut, 2016, Volume: 65, Issue:9 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome	2016
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet (London, England), 2016, 11-12, Volume: 388, Issue:10058 Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors; Taiwan; Tetracycline; Urea	2016
Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Canadian journal of gastroenterology & hepatology, 2017, Volume: 2017 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Single-Blind Method; Sulfonamides; Treatment Outcome	2017
Improving the standard sequential treatment of Helicobacter pylori with either extended treatment or by adding bismuth. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2017, Volume: 18, Issue:2 Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors	2017
Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial. Trials, 2017, Nov-17, Volume: 18, Issue:1 Topics: Amoxicillin; Clarithromycin; Clinical Protocols; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Sample Size	2017
Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study. Vojnosanitetski pregled, 2016, Volume: 73, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Biopsy; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Probiotics; Prospective Studies; Proton Pump Inhibitors; Serbia; Time Factors; Treatment Outcome; Young Adult	2016
A Prospective, randomized study comparing 7-day and 14-day quadruple therapies as first-line treatments for helicobacter pylori infection in patients with functional dyspepsia. Nigerian journal of clinical practice, 2018, Volume: 21, Issue:1 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates	2018
Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication. Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:11 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dizziness; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nausea; Patient Compliance; Prospective Studies; Proton Pump Inhibitors; Time Factors; Treatment Outcome	2018
Randomized trial of vonoprazan-based versus proton-pump inhibitor-based third-line triple therapy with sitafloxacin for Helicobacter pylori. Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:4 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastritis; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sulfonamides; Treatment Failure; Treatment Outcome	2019
Comparison between daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled trial. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2018, Volume: 37, Issue:6 Topics: Adult; Amoxicillin; Clarithromycin; Dysgeusia; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Patient Compliance; Tinidazole; Treatment Failure; Treatment Outcome; Young Adult	2018
Intraluminal therapy for Helicobacter pylori infection. Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:8 Topics: Acetylcysteine; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Expectorants; Female; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Metronidazole; Middle Aged; Powders; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Therapeutic Irrigation; Time Factors; Treatment Outcome; Young Adult	2019
Twice daily short-message-based re-education could improve Helicobacter pylori eradication rate in young population: A prospective randomized controlled study. Helicobacter, 2019, Volume: 24, Issue:3 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Patient Education as Topic; Pectins; Prospective Studies; Text Messaging; Young Adult	2019
Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Gut and liver, 2019, 09-15, Volume: 13, Issue:5 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Treatment Outcome	2019
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial. The Lancet. Infectious diseases, 2019, Volume: 19, Issue:10 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Female; Follow-Up Studies; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metabolic Syndrome; Metronidazole; Middle Aged; Organometallic Compounds; Prevalence; Tetracycline	2019
Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial. Digestive diseases and sciences, 2020, Volume: 65, Issue:12 Topics: Adenomatous Polyps; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Monitoring; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Outcome Assessment, Health Care; Proton Pump Inhibitors; Stomach Neoplasms	2020
Family History of Gastric Cancer and The New England journal of medicine, 2020, 01-30, Volume: 382, Issue:5 Topics: Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Kaplan-Meier Estimate; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms	2020
Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication. British journal of clinical pharmacology, 2022, Volume: 88, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Pyrroles; Sulfonamides; Treatment Outcome	2022
Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients. Journal of gastroenterology and hepatology, 2022, Volume: 37, Issue:7 Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Neoplasm Recurrence, Local; Pyrroles; Sulfonamides	2022
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial. Gastroenterology, 2022, Volume: 163, Issue:3 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome; United States	2022

Other Studies

162 other study(ies) available for lansoprazole and clarithromycin

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Which metabolites circulate? Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5 Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations	2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin. Zeitschrift fur Gastroenterologie, 1995, Volume: 33, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Pilot Projects; Treatment Outcome	1995
Validity of various diagnostic tests to evaluate cure of Helicobacter pylori infection. Journal of gastroenterology, 1996, Volume: 31, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Bacteriological Techniques; Breath Tests; Clarithromycin; Clinical Enzyme Tests; Clinical Laboratory Techniques; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity; Urea; Urease	1996
Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication. The American journal of gastroenterology, 1996, Volume: 91, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole	1996
Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with non-ulcer dyspesia. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1996, Volume: 47, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Electromyography; Female; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Myoelectric Complex, Migrating; Omeprazole	1996
Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. Gastroenterology, 1996, Volume: 111, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Bacterial Agents; Clarithromycin; Gene Rearrangement; Genes, Immunoglobulin; Helicobacter pylori; Humans; Immunoglobulin Heavy Chains; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole	1996
Eradication of Helicobacter pylori followed by reinfection. Journal of gastroenterology, 1996, Volume: 31 Suppl 9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Blotting, Southern; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillins; Peptic Ulcer; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Recurrence	1996
Atopic dermatitis successfully treated by eradication of Helicobacter pylori. Journal of gastroenterology, 1996, Volume: 31 Suppl 9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Blotting, Western; Clarithromycin; Dermatitis, Atopic; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors	1996
[Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia]. Leber, Magen, Darm, 1996, Volume: 26, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Roxithromycin; Treatment Outcome	1996
[Time course of disappearance of Helicobacter pylori after topical therapy and new triple therapy]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1997, Volume: 94, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Time Factors	1997
Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy. Microbiology and immunology, 1997, Volume: 41, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole	1997
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. The American journal of gastroenterology, 1997, Volume: 92, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers; Biopsy; Chronic Disease; Clarithromycin; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Juice; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Lactoferrin; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pyloric Antrum	1997
Helicobacter pylori eradication using a 7-day regimen of low-dose clarithromycin, lansoprazole and amoxycillin. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole	1997
Pharmacological therapy of Helicobacter pylori infection. Seminars in gastrointestinal disease, 1997, Volume: 8, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Compliance; Penicillins; Proton Pump Inhibitors; Tetracycline; Treatment Outcome; Vaccination	1997
[Two step therapy for education of Helicobacter pylori]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1997, Volume: 94, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors	1997
H. pylori eradication by LAC. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Food-Drug Interactions; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole	1997
Low dose, short-term, triple therapy for helicobacter pylori associated peptic ulcer. JPMA. The Journal of the Pakistan Medical Association, 1997, Volume: 47, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Peptic Ulcer	1997
Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin, and clarithromycin. Helicobacter, 1996, Volume: 1, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pilot Projects; Tetracycline; Treatment Outcome	1996
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995. Helicobacter, 1996, Volume: 1, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline; Tinidazole	1996
Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics. The Annals of pharmacotherapy, 1997, Volume: 31, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Glossitis; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Stomatitis	1997
[Successful eradication of H. pylori in an elderly patient with gastric cancer after effective UFT-E therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:15 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adenocarcinoma; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Diterpenes; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Stomach Neoplasms; Tegafur; Uracil	1997
Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori. Microbiology and immunology, 1997, Volume: 41, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Synergism; Helicobacter Infections; Helicobacter pylori; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins	1997
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea. Digestive diseases and sciences, 1998, Volume: 43, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Lansoprazole; Male; Metronidazole; Omeprazole; Peptic Ulcer; Time Factors	1998
[Sensitivity of Helicobacter pylori to amoxicillin and clarythromycin with special reference to eradication therapy]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1998, Volume: 72, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillin Resistance; Penicillins; Peptic Ulcer	1998
Analysis of the 13C-urea breath test for detection of Helicobacter pylori infection based on the kinetics of delta-13CO2 using laser spectroscopy. Journal of gastroenterology and hepatology, 1998, Volume: 13, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Proton Pump Inhibitors; Sensitivity and Specificity; Spectrum Analysis; Urea	1998
Treating Helicobacter pylori. Archives of internal medicine, 1998, Nov-23, Volume: 158, Issue:21 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine	1998
Healing of cimetidine-resistant Ménétrier's disease by eradication of Helicobacter pylori infection. Journal of clinical gastroenterology, 1998, Volume: 27, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Cimetidine; Clarithromycin; Diterpenes; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Hypoproteinemia; Lansoprazole; Omeprazole; Time Factors	1998
Relationship between the eradication of Helicobacter pylori and the healing pattern of peptic ulcer. Journal of clinical gastroenterology, 1998, Volume: 27 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Recurrence; Stomach Ulcer; Treatment Outcome; Wound Healing	1998
Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method. International journal of antimicrobial agents, 1998, Volume: 10, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Azithromycin; Biopsy; Clarithromycin; Drug Synergism; Helicobacter pylori; Humans; Kinetics; Lansoprazole; Microbial Sensitivity Tests; Omeprazole; Roxithromycin; Time Factors	1998
Effect of clarithromycin and other macrolides on the sulfoxidation and 5-hydroxylation of lansoprazole in dogs. Biological & pharmaceutical bulletin, 1999, Volume: 22, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dogs; Drug Interactions; Hydroxylation; In Vitro Techniques; Lansoprazole; Male; Microsomes, Liver; Omeprazole	1999
Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies	1999
Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori. Journal of gastroenterology, 1999, Volume: 34 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Precancerous Conditions; Stomach Neoplasms	1999
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. Journal of gastroenterology, 2000, Volume: 35, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Proton Pump Inhibitors	2000
Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients. Digestive diseases and sciences, 2000, Volume: 45, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Treatment Outcome; United States	2000
[Does eliminating Helicobacter pylori mean the healing of the duodenal ulcer? The results of a prospective study in Spain]. Gastroenterologia y hepatologia, 2000, Volume: 23, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prognosis; Prospective Studies; Remission Induction; Spain	2000
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Creatinine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Ranitidine	2000
Iron-deficiency anemia associated with Helicobacter pylori gastritis. Journal of pediatric gastroenterology and nutrition, 2000, Volume: 31, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Endoscopy, Gastrointestinal; Feces; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Iron; Lansoprazole; Male; Metronidazole; Omeprazole; Stomach; Urea	2000
Helicobacter acinonychis eradication leading to the resolution of gastric lesions in tigers. The Veterinary record, 2000, Aug-05, Volume: 147, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Carnivora; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Endoscopy; Female; Helicobacter; Helicobacter Infections; Lansoprazole; Male; Omeprazole; Penicillins; Polymerase Chain Reaction; Stomach; Stomach Ulcer	2000
Treatment of Helicobacter pylori infection: is less more? Journal of clinical gastroenterology, 2000, Volume: 31, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides; Time Factors	2000
Helicobacter pylori infection in renal transplant recipients. Transplantation proceedings, 2000, Volume: 32, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Kidney Transplantation; Lansoprazole; Male; Middle Aged; Omeprazole; Postoperative Complications; Proton Pump Inhibitors; Time Factors	2000
Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut, 2001, Volume: 48, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Omeprazole; Penicillins; Prospective Studies; Remission Induction; Stomach Neoplasms	2001
Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication. Journal of gastroenterology, 2001, Volume: 36, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Proton Pump Inhibitors; Remission Induction; Stomach Neoplasms	2001
A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication. Gastrointestinal endoscopy, 2001, Volume: 53, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Endosonography; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Plasmacytoma; Stomach Neoplasms; Treatment Outcome	2001
Effects of lansoprazole, clarithromycin and pH gradient on uptake of [14C]amoxycillin into rat gastric tissue. The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Ulcer Agents; Biological Transport; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Duodenum; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Penicillins; Peptic Ulcer; Rats; Rats, Wistar	2001
Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection. Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Recurrence; Retrospective Studies; Treatment Failure	2001
Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori. Gastrointestinal endoscopy, 2001, Volume: 54, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Ampulla of Vater; Biopsy; Clarithromycin; Common Bile Duct Neoplasms; Drug Therapy, Combination; Duodenal Neoplasms; Endosonography; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lansoprazole; Lymphoma, Follicular; Male; Middle Aged; Omeprazole	2001
Pseudomembranous colitis without diarrhoea following Helicobacter pylori eradication therapy. Hospital medicine (London, England : 1998), 2001, Volume: 62, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Occult Blood; Omeprazole; Penicillins	2001
Resolution of Ménétrier's disease after Helicobacter pylori eradicating therapy. Digestive diseases (Basel, Switzerland), 2001, Volume: 19, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome	2001
Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice. Archives of internal medicine, 2001, Sep-24, Volume: 161, Issue:17 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antibodies, Bacterial; Antigens, Bacterial; Breath Tests; Clarithromycin; Cohort Studies; Costs and Cost Analysis; Decision Support Techniques; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Predictive Value of Tests; Recurrence; Unnecessary Procedures	2001
Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Health Care Costs; Helicobacter Infections; Humans; Lansoprazole; Markov Chains; Omeprazole; Penicillins; Stomach Ulcer; Treatment Outcome	2001
Effects of lansoprazole and amoxicillin on uptake of [(14)C]clarithromycin into gastric tissue in rats. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Interactions; Duodenum; Gastric Mucosa; Gastrointestinal Contents; In Vitro Techniques; Injections, Intravenous; Lansoprazole; Male; Omeprazole; Penicillins; Rats; Rats, Wistar; Stomach; Tissue Distribution	2001
Localization of [14C]amoxicillin in rat gastric tissue when administered with lansoprazole and clarithromycin. The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbon Radioisotopes; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Lansoprazole; Male; Omeprazole; Penicillins; Rats; Rats, Wistar	2001
Fine-needle aspiration biopsy of an intra-abdominal inflammatory mass secondary to a penetrating duodenal ulcer mimicking neoplasm. Diagnostic cytopathology, 2001, Volume: 25, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Biopsy, Needle; Clarithromycin; Diagnosis, Differential; Duodenal Ulcer; Duodenitis; Duodenum; Endoscopy, Digestive System; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pancreatic Neoplasms; Tomography, X-Ray Computed	2001
Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy. International journal of antimicrobial agents, 2002, Volume: 19, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies	2002
[Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2001, Volume: 42, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Penicillins; Purpura, Thrombocytopenic, Idiopathic	2001
[Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2002, Volume: 9, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Data Interpretation, Statistical; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Lansoprazole; Male; Metronidazole; Omeprazole; Penicillin Resistance; Penicillins; Retrospective Studies	2002
Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. The American journal of gastroenterology, 2002, Volume: 97, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Antigens; Clarithromycin; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Sensitivity and Specificity; Time Factors; Treatment Outcome	2002
[Gastroduodenal ulcer in childhood]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Informed Consent; Japan; Lansoprazole; Male; Omeprazole; Peptic Ulcer; Practice Guidelines as Topic; Treatment Failure	2002
Failure of Helicobacter pylori eradication: is poor compliance the main cause? Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Peptic Ulcer; Treatment Failure	2002
[Eradication of helicobacter pylori: symptomatic treatment of reflux disease?]. Zeitschrift fur Gastroenterologie, 2002, Volume: 40, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Esophagitis, Peptic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Randomized Controlled Trials as Topic	2002
Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection. Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Hematologic Tests; Humans; Lansoprazole; Omeprazole; Penicillins; Treatment Outcome	2002
Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. British journal of haematology, 2002, Volume: 118, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Blood Platelets; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Platelet Count; Purpura, Thrombocytopenic, Idiopathic	2002
Localization of [14C]clarithromycin in rat gastric tissue when administered with lansoprazole and amoxicillin. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Amoxicillin; Animals; Carbon Radioisotopes; Clarithromycin; Drug Interactions; Gastric Mucosa; Injections, Intravenous; Intestinal Mucosa; Intubation, Gastrointestinal; Lansoprazole; Male; Omeprazole; Rats; Rats, Wistar; Stomach	2002
Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori. Helicobacter, 2002, Volume: 7, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Phospholipids; Stomach Ulcer; Treatment Outcome	2002
One week regimen of esomeprazole based triple therapy is sufficient for duodenal ulcer healing and Helicobacter pylori eradication in patients with duodenal ulcer disease. European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Prospective Studies; Treatment Outcome	2002
Effects of clarithromycin and amoxicillin on gastric emptying in rats. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Infective Agents; Carbon Radioisotopes; Clarithromycin; Drug Therapy, Combination; Duodenum; Gastric Emptying; Gastric Mucosa; Lansoprazole; Male; Omeprazole; Rats; Rats, Wistar	2002
Regression of CD5-positive and Helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma of the rectum after administration of antibiotics: report of a case. Diseases of the colon and rectum, 2002, Volume: 45, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; CD5 Antigens; Clarithromycin; Colonoscopy; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Penicillins; Rectal Neoplasms	2002
Pseudomembranous colitis requiring surgical intervention following triple therapy for Helicobacter pylori eradication. ANZ journal of surgery, 2002, Volume: 72, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Clarithromycin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole	2002
Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin. Epidemiology and infection, 2003, Volume: 130, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Fucosyltransferases; Genotype; Helicobacter pylori; Humans; Lansoprazole; Lewis Blood Group Antigens; Male; Middle Aged; Omeprazole; Polymorphism, Genetic; Prospective Studies; Smoking	2003
Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori. Journal of gastroenterology, 2003, Volume: 38, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole	2003
Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2003, Volume: 86, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome	2003
Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure	2003
Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication. Langenbeck's archives of surgery, 2004, Volume: 389, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cell Transformation, Neoplastic; Clarithromycin; Female; Gastrectomy; Gastric Mucosa; Gastroenterostomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Neoplasm Recurrence, Local; Omeprazole; Stomach Neoplasms; Treatment Outcome	2004
[Successful treatment of long-standing iron-deficiency anemia in adults by eradication of Helicobacter pylori]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2004, Volume: 45, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole	2004
Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Platelet Count; Remission Induction; Thrombocytopenia	2004
Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis. Alimentary pharmacology & therapeutics, 2004, Volume: 20 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Stomach Ulcer; Treatment Outcome	2004
Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils. Cancer science, 2004, Volume: 95, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Apoptosis; Cell Proliferation; Choristoma; Clarithromycin; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Intestines; Lansoprazole; Omeprazole; Stomach	2004
Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population. Journal of gastroenterology, 2004, Volume: 39, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Proton Pump Inhibitors	2004
Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Area Under Curve; Chemistry, Pharmaceutical; Clarithromycin; Drug Combinations; Female; Gastritis; Half-Life; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Immunoglobulin G; Lansoprazole; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Omeprazole; Penicillins; Sucralfate; Viscosity	2004
Results of triple eradication therapy in Japanese children: a retrospective multicenter study. Journal of gastroenterology, 2004, Volume: 39, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Humans; Infant; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Sulfoxides	2004
Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003. Helicobacter, 2005, Volume: 10, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Rabeprazole; Tokyo	2005
Influence of antimicrobial treatment for Helicobacter pylori infection on the intestinal microflora in Japanese macaques. Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Clarithromycin; Enterobacteriaceae; Enterococcus; Feces; Helicobacter Infections; Helicobacter pylori; Intestines; Lansoprazole; Macaca; Omeprazole; Proton Pump Inhibitors	2005
Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. Virchows Archiv : an international journal of pathology, 2005, Volume: 446, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gene Rearrangement; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin Heavy Chains; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Prognosis; Remission Induction; Stomach Neoplasms	2005
Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils. World journal of gastroenterology, 2005, Feb-21, Volume: 11, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Lansoprazole; Male; Omeprazole; Specific Pathogen-Free Organisms	2005
Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms? Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Rosacea	2005
Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication. Digestive diseases and sciences, 2005, Volume: 50, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome	2005
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2005, Volume: 3, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Biopsy; Clarithromycin; Colony Count, Microbial; Cytochrome P-450 CYP2C19; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Omeprazole; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Ribosomal, 23S; Treatment Outcome	2005
Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients. Pathology international, 2005, Volume: 55, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Japan; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Microscopy, Electron, Transmission; Middle Aged; Omeprazole; Stomach; Treatment Outcome	2005
Determinants of non-response in Helicobacter pylori eradication trials. Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Treatment Failure	2005
Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2006, Volume: 19, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Cyclin-Dependent Kinase Inhibitor p27; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Interleukin-8; Lansoprazole; Male; Middle Aged; Omeprazole; Proteins; Proto-Oncogene Proteins c-myc; Proton Pump Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; S-Phase Kinase-Associated Proteins	2006
CagA status and Helicobacter pylori eradication among dyspeptic patients. Gastroenterologia y hepatologia, 2005, Volume: 28, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Biomarkers; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme-Linked Immunosorbent Assay; Eosinophilia; Eosinophils; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphocytes; Male; Middle Aged; Omeprazole; Peptic Ulcer	2005
[The cause of failure of eradication treatment of Helicobacter pylori]. Rinsho byori. The Japanese journal of clinical pathology, 2005, Volume: 53, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome	2005
Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy. Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dyspepsia; Female; Gastrointestinal Diseases; Gastrointestinal Motility; Gastrointestinal Tract; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pain Measurement; Quality of Life; Stomach Ulcer; Surveys and Questionnaires	2005
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori? The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2005, Volume: 16, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lansoprazole; Male; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Stomach Ulcer; Treatment Outcome	2005
Helicobacter pylori treatment. Southern medical journal, 2005, Volume: 98, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Expectorants; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole	2005
[Pseudomembranous colitis after Helicobacter pylori eradication therapy]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2006, Volume: 80, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole	2006
Influence of smoking and CYP2C19 genotypes on H. pylori eradication success. Epidemiology and infection, 2007, Volume: 135, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Polymorphism, Genetic; Smoking; Treatment Outcome	2007
Contrast-enhanced ultrasonographic assessment of the response of Ménétrier disease to Helicobacter pylori eradication therapy. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2006, Volume: 25, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Contrast Media; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Polysaccharides; Ultrasonography	2006
The Efficacy of Helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura--the first study in Turkey. Acta haematologica, 2006, Volume: 116, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Purpura, Thrombocytopenic, Idiopathic; Turkey	2006
Some fibrocystic breast change may be caused by sexually transmitted H. pylori during oral nipple contact: supporting literature and case report of resolution after gut H. pylori eradication treatment. Medical hypotheses, 2007, Volume: 68, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Clarithromycin; Female; Fibrocystic Breast Disease; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Models, Biological; Nipples; Serologic Tests; Time Factors; Treatment Outcome; Ultrasonography	2007
Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2006, Volume: 9, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Stomach Neoplasms	2006
Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura. Platelets, 2007, Volume: 18, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Stomach Ulcer	2007
Influence of H pylori on plasma ghrelin in patients without atrophic gastritis. World journal of gastroenterology, 2007, Mar-14, Volume: 13, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Ghrelin; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Peptide Hormones; Turkey	2007
A better cure rate with 800 mg than with 400 mg clarithromycin regimens in one-week triple therapy for Helicobacter pylori infection in cigarette-smoking peptic ulcer patients. Digestion, 2007, Volume: 75, Issue:2-3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Retrospective Studies; Smoking; Statistics, Nonparametric; Treatment Outcome	2007
Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori. Alimentary pharmacology & therapeutics, 2007, Sep-01, Volume: 26, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Polymorphism, Restriction Fragment Length; Treatment Outcome	2007
Pyroderma gangrenosum: resolution after treatment for Helicobacter pylori. Journal of the South Carolina Medical Association (1975), 2006, Volume: 102, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Pyoderma Gangrenosum	2006
Effect of Helicobacter pylori eradication on gastric carcinogenesis. Laboratory investigation; a journal of technical methods and pathology, 2008, Volume: 88, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Amoxicillin; Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Interferon-gamma; Lansoprazole; Male; Specific Pathogen-Free Organisms; Stomach Neoplasms; Time Factors	2008
Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2008, Volume: 6, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Antibodies; Biopsy; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metaplasia; Middle Aged; Phenotype; Prospective Studies; Stomach; Stomach Neoplasms; Tropomyosin; Tumor Suppressor Protein p53	2008
Reflux masquerader: acute Helicobacter pylori infection in neonates and infants. Journal of pediatric gastroenterology and nutrition, 2008, Volume: 46, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Lansoprazole; Male; Proton Pump Inhibitors; Treatment Outcome	2008
Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment. Gastrointestinal endoscopy, 2008, Volume: 68, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoid Tissue; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Pilot Projects; Retrospective Studies; Stomach Neoplasms	2008
A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen. Digestion, 2008, Volume: 78, Issue:2-3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alopecia; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colonic Polyps; Colonoscopy; Gastritis; Helicobacter Infections; Humans; Hyperpigmentation; Intestinal Polyposis; Lansoprazole; Male; Syndrome	2008
[Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2008, Volume: 52, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole	2008
Iron deficiency anemia successfully treated by Helicobacter pylori eradication in a patient with idiopathic thrombocytopenic purpura. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2009, Volume: 50, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anemia, Iron-Deficiency; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome	2009
Ten-day sequential therapy of Helicobacter pylori infection in Thailand. The American journal of gastroenterology, 2010, Volume: 105, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Patient Compliance; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Thailand; Time Factors; Treatment Outcome; Young Adult	2010
Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Journal of gastrointestinal cancer, 2010, Volume: 41, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Immunoproliferative Small Intestinal Disease; Lansoprazole; Male; Omeprazole; Organometallic Compounds; Tinidazole; Young Adult	2010
The effectiveness of packed therapy with three drugs in Helicobacter pylori eradication in Japan. Methods and findings in experimental and clinical pharmacology, 2010, Volume: 32, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies	2010
Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2010, Volume: 21, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Cytochrome P-450 Enzyme System; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Polymorphism, Genetic; Proton Pump Inhibitors	2010
Age-dependent eradication of Helicobacter pylori in Japanese patients. World journal of gastroenterology, 2010, Sep-07, Volume: 16, Issue:33 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Logistic Models; Male; Middle Aged; Retrospective Studies; Treatment Failure	2010
Long term changes in platelet counts after H. pylori eradication in non-ITP patients. Platelets, 2010, Volume: 21, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic	2010
Changes in gastric mucosal patterns seen by magnifying NBI during H. pylori eradication. Journal of gastroenterology, 2011, Volume: 46, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Image Enhancement; Lansoprazole; Male; Middle Aged; Sensitivity and Specificity; Severity of Illness Index	2011
Partial regression of duodenal lesions of intestinal follicular lymphoma after antibiotic treatment. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2010, Volume: 22, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Clarithromycin; Drug Therapy, Combination; Duodenal Neoplasms; Endoscopy, Gastrointestinal; Humans; Lansoprazole; Lymphoma, Follicular; Male; Middle Aged	2010
A new strategy of transforming pharmaceutical crystal forms. Journal of the American Chemical Society, 2011, Feb-09, Volume: 133, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Carbon Dioxide; Clarithromycin; Crystallography, X-Ray; Ethanol; Gases; Lansoprazole; Models, Molecular; Molecular Conformation; Pressure; Temperature	2011
Sequential therapy in clarithromycin-sensitive and -resistant Helicobacter pylori based on polymerase chain reaction molecular test. Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Chi-Square Distribution; Clarithromycin; DNA, Bacterial; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastroscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nitroimidazoles; Odds Ratio; Point Mutation; Polymerase Chain Reaction; Predictive Value of Tests; Proton Pump Inhibitors; Ribotyping; Risk Assessment; Risk Factors; RNA, Ribosomal, 23S; Thailand; Time Factors; Treatment Outcome	2011
Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2011, Volume: 131, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Blood Specimen Collection; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Monitoring; Fluvoxamine; Genotype; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole	2011
Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura. Journal of gastroenterology, 2011, Volume: 46, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Atrophic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Pepsinogens; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome	2011
Improvements in Helicobacter pylori eradication rates through clinical CYP2C19 genotyping. Nagoya journal of medical science, 2011, Volume: 73, Issue:1-2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Middle Aged; Pharmacogenetics; Proton Pump Inhibitors; Rabeprazole; Young Adult	2011
Does long-term aspirin use have any effect on Helicobacter pylori eradication? The American journal of the medical sciences, 2011, Volume: 342, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Case-Control Studies; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Pilot Projects; Prospective Studies; Time Factors; Treatment Outcome	2011
Helicobacter pylori infection-related pancytopenia in a young boy. Pediatric hematology and oncology, 2011, Volume: 28, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anemia, Megaloblastic; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Pancytopenia; Vitamin B 12; Vitamin B 12 Deficiency	2011
Mass eradication of Helicobacter pylori: feasible and advisable? Lancet (London, England), 2011, Aug-06, Volume: 378, Issue:9790 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Drugs, Generic; Feasibility Studies; Female; Health Policy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Latin America; Male; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Neoplasms	2011
Role of gastritis pattern on Helicobacter pylori eradication. Internal and emergency medicine, 2012, Volume: 7, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Young Adult	2012
Comparison of sequential and standard therapy for Helicobacter pylori eradication in children and investigation of clarithromycin resistance. Journal of pediatric gastroenterology and nutrition, 2012, Volume: 55, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole	2012
Education and imaging. Gastrointestinal: colonic mucosa-associated lymphoid tissue lymphoma regressed by levofloxacin. Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colonic Neoplasms; Colonoscopy; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Endosonography; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lansoprazole; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Multimodal Imaging; Occult Blood; Ofloxacin; Polymerase Chain Reaction; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2013, Volume: 37, Issue:12 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Acidity Determination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Metronidazole; Middle Aged; Peptic Ulcer; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome	2013
Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area. Helicobacter, 2013, Volume: 18, Issue:6 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Retrospective Studies; Tokyo; Young Adult	2013
What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study. Clinics and research in hepatology and gastroenterology, 2013, Volume: 37, Issue:6 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Breath Tests; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Stomach; Tetracycline; Treatment Outcome; Urea; Young Adult	2013
Complete regression of early-stage gastric diffuse large B-cell lymphoma in an HIV-1-infected patient following Helicobacter pylori eradication therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:10 Topics: Adenine; Amoxicillin; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; HIV-1; Humans; Lansoprazole; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; Tenofovir	2014
Cure rate of Helicobacter pylori infection in Egyptian children related to CYP2C19 gene polymorphism. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2014, Volume: 33, Issue:4 Topics: Amoxicillin; Child; Clarithromycin; Cytochrome P-450 CYP2C19; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Severity of Illness Index; Treatment Outcome	2014
[Ten day concomitant therapy is superior to ten day sequential therapy for Helicobacter pylori eradication]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2014, Volume: 64, Issue:5 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Treatment Outcome	2014
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group). Journal of gastroenterology and hepatology, 2014, Volume: 29 Suppl 4 Topics: Amoxicillin; Chronic Disease; Clarithromycin; Disease Eradication; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Time Factors; Tokyo	2014
Pediatric Pharyngeal IgD-positive Monoclonal Plasmacytoid and Plasma Cell Neoplasm. Journal of pediatric hematology/oncology, 2015, Volume: 37, Issue:8 Topics: Adolescent; Amoxicillin; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clarithromycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunocompetence; Immunoglobulin D; Lansoprazole; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Paraproteins; Pharyngeal Neoplasms; Plasma Cells; Plasmablastic Lymphoma; Postoperative Complications; Prednisone; Remission Induction; Tonsillectomy; Vincristine	2015
Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2015, Volume: 26, Issue:6 Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Ascorbic Acid; Breath Tests; Clarithromycin; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Organometallic Compounds; Retrospective Studies; Treatment Outcome; Vitamin E; Vitamins; Young Adult	2015
Does the urea breath test predict eradication of Helicobacter pylori infection? Acta gastro-enterologica Belgica, 2016, Volume: 79, Issue:1 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Radioisotopes; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Urea	2016
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection. European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:2 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Retrospective Studies	2016
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion. The Journal of laryngology and otology, 2016, Volume: 130, Issue:3 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Otitis Media with Effusion; Proton Pump Inhibitors	2016
Severe Helicobacter pylori gastritis-related thrombocytopenia and iron deficiency anemia in an adolescent female. Annals of hematology, 2016, Volume: 95, Issue:5 Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Breath Tests; Clarithromycin; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulins, Intravenous; Iron; Lansoprazole; Purpura, Thrombocytopenic; Remission Induction	2016
Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointestinal endoscopy, 2016, Volume: 84, Issue:4 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Breath Tests; Clarithromycin; Cohort Studies; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Proportional Hazards Models; Proton Pump Inhibitors; Pyloric Antrum; Retrospective Studies; Risk Factors; Stomach; Stomach Neoplasms	2016
The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy. The American journal of gastroenterology, 2016, Volume: 111, Issue:7 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Monitoring; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Retrospective Studies; Sulfonamides; Treatment Outcome	2016
Authors' reply. The Journal of laryngology and otology, 2016, Volume: 130, Issue:3 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Otitis Media with Effusion; Proton Pump Inhibitors	2016
An assessment of the efficacy of first-line Helicobacter pylori-eradication therapy based on clarithromycin susceptibility. Minerva gastroenterologica e dietologica, 2016, Volume: 62, Issue:3 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies	2016
Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection. BMC gastroenterology, 2016, Oct-04, Volume: 16, Issue:1 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Body Mass Index; Body Weight; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis, Atrophic; Ghrelin; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Leptin; Male; Middle Aged; Peptic Ulcer	2016
Liquid Chromatographic-Chemometric Techniques for the Simultaneous HPLC Determination of Lansoprazole, Amoxicillin and Clarithromycin in Commercial Preparation. Journal of chromatographic science, 2017, Sep-01, Volume: 55, Issue:8 Topics: Amoxicillin; Chromatography, High Pressure Liquid; Clarithromycin; Lansoprazole; Linear Models; Multivariate Analysis; Reproducibility of Results; Tablets	2017
Helicobacter pylori eradication may successfully treat primary cutaneous follicle center lymphoma. Helicobacter, 2018, Volume: 23, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Doxycycline; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell; Metronidazole; Middle Aged; Organometallic Compounds; Rabeprazole; Salicylates	2018
Helicobacter suis infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma. Cancer medicine, 2019, Volume: 8, Issue:9 Topics: Adult; Amoxicillin; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Prevalence; Treatment Outcome	2019
Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication. The Journal of dermatology, 2020, Volume: 47, Issue:3 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Erythema Multiforme; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sex Factors; Stevens-Johnson Syndrome; Sulfonamides	2020
Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study. Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:8 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Sex Factors; Young Adult	2021